Prof Cherrie Galletly
School of Medicine
College of Health
Emerita Professor Cherrie Galletly is a consultant psychiatrist working across the University, public mental health and private sectors. She was Interim Dean of the Adelaide Medical School 2020-2021, responsible for managing the MBBS program during the COVID-19 pandemic. She was awarded an OAM for her services to psychiatry, in 2022. She held a Chair in Psychiatry, jointly funded by the University of Adelaide and Ramsay Health Care (SA) Mental Health, from 2007 until May 2022. She continues as a Regional Director of Postgraduate Psychiatry training (Northern Area Local Health Network). She takes a collaborative approach to research, with the ultimate goal of improving the quality of care for people with severe mental illness. Her research interests include schizophrenia and other psychotic disorders; she was Northern Adelaide site director for the Second National Survey of Psychosis (2010) a landmark study of more than 1800 people with psychoses. She was a member of the NHMRC Mental Health Research Advisory Committee (MHRAC) 2017-2019.She was a Chief Investigator on a study of comorbidity between mental health and substance abuse disorder based in the Northern suburbs of Adelaide. She heads up one of the leading national centres on neurostimulation treatments (rTMS and ECT) for psychiatric disorders. She led the Writing Group for the RANZCP Clinical Practise Guidelines for Schizophrenia and Related Disorders. She was an Associate Editor for the Australian and New Zealand Journal of Psychiatry (2011-2021) and a member of the Editorial Executive for Australian Prescriber (2011-2020). She has worked with many early career researchers and clinicians to publish their first paper. She has supervised many HDR students including supervising seven PhDs to completion.She has more than 300 publications in the peer reviewed literature, along with one book and 3 book chapters. Since 2011 she has been involved in 61 conference presentations. Her total collaborative research funding exceeds $30m.
| Date | Position | Institution name |
|---|---|---|
| 2012 - ongoing | Regional Director of Training | Northern Mental Health, NALHN |
| 2007 - ongoing | Emerita Professor | University of Adelaide |
| Year | Citation |
|---|---|
| 2026 | Paris, J., Laurendi, O., Arnet, V., & Galletly, C. (2026). Cannabis use and cardiometabolic risk in schizophrenia. Schizophrenia Research, 287, 54-62. |
| 2026 | Suetani, S., Dark, F., Every-Palmer, S., Galletly, C., O’Donoghue, B., Halstead, S., . . . Siskind, D. (2026). Australian and New Zealand Journal of Psychiatry Grading of Recommendations, Assessment, Development and Evaluations (GRADE) guidelines for the management of schizophrenia. Australian and New Zealand Journal of Psychiatry, 60(4 Special Issue: Schizophrenia Guidelines), 367-404. Scopus1 |
| 2026 | Suetani, S., Galletly, C., Lawn, S., & Siskind, D. (2026). New guidelines for management of schizophrenia in Australia and Aotearoa New Zealand. Australian and New Zealand Journal of Psychiatry, 60(4 Special Issue: Schizophrenia Guidelines), 305-307. |
| 2026 | Nguyen, Q. K. D., Solanki, P., Thomas, E. H. X., Cerins, A., Hahn, L., Galletly, C., . . . Chen, L. (2026). Response to “Letter to the editor regarding: “Lack of early reduction in depression severity predicts treatment non-response with 10 Hz and accelerated theta burst repetitive transcranial magnetic stimulation in treatment-resistant depression” by Nguyen et al. (2025)”. Journal of Affective Disorders, 394(Pt A), 2 pages. |
| 2025 | Sharmil, H., Galletly, C., Kelly, J., Wilkes, T., George, A., Jaison, M., . . . Annamalai, K. (2025). Awareness of access to health care: a significant need of the Narikuravar people, India. Rural and Remote Health, 25(4), 7 pages. |
| 2025 | Christodoulou, V., Liu, D., Esterman, A., & Galletly, C. (2025). 'Facilitators and barriers to recruitment in mental health research: A survey of psychiatrists and psychiatry registrars in training'. Australasian Psychiatry, 33(1), 153-161. Scopus1 WoS1 Europe PMC1 |
| 2025 | Nguyen, Q. K. D., Solanki, P., Thomas, E. H. X., Cerins, A., Hahn, L., Galletly, C., . . . Chen, L. (2025). Lack of early reduction in depression severity predicts treatment non-response with 10 Hz and accelerated theta burst repetitive transcranial magnetic stimulation in treatment-resistant depression. Journal of Affective Disorders, 385, 11 pages. Scopus3 WoS3 |
| 2025 | Gill, S., & Galletly OAM, C. (2025). ‘I, robot, can help you’. Applications of Generative Artificial Intelligence in RANZCP psychiatry training. Australasian Psychiatry, 33(4), 689-692. Scopus1 WoS1 |
| 2025 | Halstead, S., Yap, C. X., Warren, N., Agarwal, S. M., Brand, B. A., Chan, S. K. W., . . . McCutcheon, R. A. (2025). Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health Commission. Lancet Psychiatry, 12(9), 673-699. Scopus11 Europe PMC6 |
| 2025 | Burford, C., Proctor, J., Thomson, S., Toh, J., Schubert, K. O., & Galletly, C. (2025). Clinical characteristics of people referred for Medicare Item 291 Psychiatric Assessments in northern metropolitan Adelaide. Australasian Psychiatry, 33(6), 916-922. |
| 2025 | Galletly, C. (2025). Antipsychotic augmentation of clozapine. Australasian Psychiatry, 33(2), 303. Scopus1 WoS1 |
| 2024 | Galbally, M., Kotze, B., Bell, C., Quadrio, C., Galletly, C., Herrman, H., . . . Morgan, S. (2024). Achieving gender equity in academic psychiatry – barriers to involvement and solutions for success. Australasian Psychiatry, 32(6), 563-567. Scopus2 Europe PMC1 |
| 2024 | Weickert, T. W., Jacomb, I., Lenroot, R., Lappin, J., Weinberg, D., Brooks, W. S., . . . Shannon Weickert, C. (2024). Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial. Brain, Behavior, and Immunity, 115, 191-200. Scopus29 WoS24 Europe PMC24 |
| 2024 | Weickert, T. W., Ji, E., Galletly, C., Boerrigter, D., Morishima, Y., Bruggemann, J., . . . Kindler, J. (2024). Toll-Like Receptor mRNA Levels in Schizophrenia: Association With Complement Factors and Cingulate Gyrus Cortical Thinning. Schizophrenia Bulletin, 50(2), 403-417. Scopus9 WoS9 Europe PMC8 |
| 2024 | Tran, L., Hahn, L., Gill, S., Ng, F., Clarke, P., Paterson, T., & Galletly, C. (2024). Do benzodiazepines reduce the efficacy of transcranial magnetic stimulation?. Australasian Psychiatry, 32(3), 180-185. Scopus5 WoS2 Europe PMC1 |
| 2023 | Arnautovska, U., Vitangcol, K., Kesby, J. P., Warren, N., Rossell, S. L., Neill, E., . . . Siskind, D. (2023). Verbal and visual learning ability in patients with treatment-resistant schizophrenia: A 1-year follow-up study. Schizophrenia Research: Cognition, 33, 100283-1-100283-7. Scopus8 |
| 2023 | Lindell‐Innes, R., Phillips‐Hughes, A. L., Bartsch, D., Galletly, C., & Ludbrook, C. (2023). Attitudes of psychiatry trainees towards patients with borderline personality disorder: Does the stigma begin during training?. Personality and Mental Health, 17(4), 387-395. Scopus14 WoS14 Europe PMC8 |
| 2022 | Thomson, S., Galletly, C., Prener, C., Garverich, S., Liu, D., & Lincoln, A. (2022). Associations between health literacy, cognitive function and general literacy in people with schizophrenia attending community mental health clinics in Australia.. BMC Psychiatry, 22(1), 9 pages. Scopus8 WoS8 Europe PMC6 |
| 2022 | Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Benyamin, B., & O'Donovan, M. C. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502-508. Scopus1845 WoS1785 Europe PMC2274 |
| 2022 | Chen, L., Thomas, E. H. X., Kaewpijit, P., Miljevic, A., Hahn, L., Lavale, A., . . . Fitzgerald, P. B. (2022). Does switching between high frequency rTMS and theta burst stimulation improve depression outcomes?. Brain Stimulation, 15(4), 889-891. Scopus4 WoS3 Europe PMC2 |
| 2022 | Sigrist, C., Vöckel, J., MacMaster, F. P., Farzan, F., Croarkin, P. E., Galletly, C., . . . Koenig, J. (2022). Transcranial magnetic stimulation in the treatment of adolescent depression: a systematic review and meta-analysis of aggregated and individual-patient data from uncontrolled studies. European Child and Adolescent Psychiatry, 31(10), 1501-1525. Scopus53 Europe PMC32 |
| 2022 | Neill, E., Rossell, S. L., Yolland, C., Meyer, D., Galletly, C., Harris, A., . . . Castle, D. J. (2022). N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms. Schizophrenia bulletin, 48(6), 1263-1272. Scopus28 WoS27 Europe PMC22 |
| 2022 | Condon, J., Stewart, C., & Galletly, C. (2022). Is PTSD a Bodily Injury?. Journal of Law and Medicine, 29(3), 888-894. |
| 2022 | Nguyen, H., Haeney, O., & Galletly, C. (2022). The characteristics of older homicide offenders: a systematic review. Psychiatry, Psychology and Law, 29(3), 413-430. Scopus8 WoS8 Europe PMC2 |
| 2022 | Ji, E., Boerrigter, D., Cai, H. Q., Lloyd, D., Bruggemann, J., O'Donnell, M., . . . Shannon Weickert, C. (2022). Peripheral complement is increased in schizophrenia and inversely related to cortical thickness. Brain, Behavior, and Immunity, 101, 423-434. Scopus33 WoS31 Europe PMC30 |
| 2022 | Amir Izzat, J., Cherrie, G., & Nick, F. (2022). Improving services for those who serve: A private practice initiative to improve psychiatric care for first responder and military patients. Australasian Psychiatry, 30(3), 103985622110578. |
| 2022 | Fitzgerald, P. B., Gill, S., Breakspear, M., Kulkarni, J., Chen, L., Pridmore, S., . . . Hoy, K. E. (2022). Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again. Australian & New Zealand Journal of Psychiatry, 56(8), 905-909. Scopus9 WoS10 Europe PMC5 |
| 2022 | Lam, N. S. K., Long, X. X., Li, X., Saad, M., Lim, F., Doery, J. C., . . . Galletly, C. (2022). The potential use of folate and its derivatives in treating psychiatric disorders: A systematic review. Biomedicine and Pharmacotherapy, 146, 18 pages. Scopus49 WoS42 Europe PMC34 |
| 2022 | Murphy, C. E., Walker, A. K., O’Donnell, M., Galletly, C., Lloyd, A. R., Liu, D., . . . Weickert, T. W. (2022). Peripheral NF-κB dysregulation in people with schizophrenia drives inflammation: putative anti-inflammatory functions of NF-κB kinases. Translational Psychiatry, 12(1), 11 pages. Scopus33 WoS32 Europe PMC28 |
| 2022 | Galletly, C. A. (2022). Effective family interventions for people with schizophrenia. Lancet Psychiatry, 9(3), 185-187. Scopus4 WoS3 Europe PMC3 |
| 2021 | Giam, A., Chen, L., Lisa Hahn., Gill, S., Clarke, P., Ng, F., . . . Fitzgerald, P. (2021). Comparing theta burst stimulation with standard left high frequency transcranial magnetic stimulation in the treatment of depression in a randomized controlled study: A preliminary comparison study. Journal of Affective Disorders Reports, 5, 100162-1-100162-7. Scopus7 |
| 2021 | Arnautovska, U., Neill, E., Rossell, S. L., Yolland, C., Galletly, C., Harris, A., . . . Siskind, D. (2021). Does the clozapine/norclozapine ratio predict cognitive performance in patients with clozapine-resistant schizophrenia?. Australian and New Zealand Journal of Psychiatry, 56(7), 875-878. Scopus6 WoS6 Europe PMC5 |
| 2021 | Ford, H., Hahn, L., Clarke, P., Gill, S., Carnell, B., & Galletly, C. (2021). A comparison of 15 minute vs 30 minute repetitive transcranial magnetic stimulation sessions for treatment resistant depression – are longer treatment sessions more effective?. Journal of Affective Disorders, 282, 974-978. Scopus4 WoS4 Europe PMC3 |
| 2021 | Galletly, C., Suetani, S., Hahn, L., McKellar, D., & Castle, D. (2021). Ageing with psychosis – Fifty and beyond. Australian & New Zealand Journal of Psychiatry, 56(1), 39-49. Scopus4 WoS4 Europe PMC3 |
| 2021 | Bampton, T. J., Hack, D., & Galletly, C. A. (2021). Clozapine treatment for Huntington's disease psychosis.. The Australian and New Zealand journal of psychiatry, 56(2), 48674211013082. Scopus8 WoS6 Europe PMC3 |
| 2021 | Enticott, P. G., Barlow, K., Guastella, A. J., Licari, M. K., Rogasch, N. C., Middeldorp, C. M., . . . Fitzgerald, P. B. (2021). Repetitive transcranial magnetic stimulation (rTMS) in autism spectrum disorder: protocol for a multicentre randomised controlled clinical trial. BMJ Open, 11(7), e046830-1-e046830-9. Scopus20 WoS20 Europe PMC15 |
| 2021 | Sharmil, H., Kelly, J., Bowden, M., Galletly, C., Cairney, I., Wilson, C., . . . de Crespigny, C. (2021). Participatory Action Research-Dadirri-Ganma, using Yarning: methodology co-design with Aboriginal community members. International Journal for Equity in Health, 20(1), 160-1-160-11. Scopus59 WoS44 Europe PMC26 |
| 2021 | Chen, L., Thomas, E. H., Kaewpijit, P., Miljevic, A., Hughes, R., Hahn, L., . . . Fitzgerald, P. B. (2021). Accelerated theta burst stimulation for the treatment of depression: a randomised controlled trial. Brain Stimul, 14(5), 1095-1105. Scopus86 WoS77 Europe PMC75 |
| 2021 | Chen, L., Thomas, E. H. X., Kaewpijit, P., Miljevic, A., Hughes, R., Hahn, L., . . . Fitzgerald, P. B. (2021). Corrigendum to, 'Accelerated theta burst stimulation for the treatment of depression: A randomised controlled trial' [Brain Stimulat. 14(5) (2021) 1095-1105].. Brain stimulation, 14(5), 1218. |
| 2021 | Jernbom Falk, A., Galletly, C., Just, D., Toben, C., Baune, B. T., Clark, S. R., . . . Schubert, K. O. (2021). Autoantibody profiles associated with clinical features in psychotic disorders. Translational Psychiatry, 11(1), 1-9. Scopus27 WoS26 Europe PMC26 |
| 2020 | Galletly, C., Ash, D., Sweeney, S., O'Neill, F., & Crichton, J. (2020). Identifying and exploring linguistic expertise of psychiatrists in interviews with patients with thought disorder.. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 28(2), 193-198. WoS1 |
| 2020 | Ji, E., Weickert, C. S., Purves-Tyson, T., White, C., Handelsman, D. J., Desai, R., . . . Weickert, T. W. (2020). Cortisol-dehydroepiandrosterone ratios are inversely associated with hippocampal and prefrontal brain volume in schizophrenia. Psychoneuroendocrinology, 123, 104916. Scopus14 WoS12 Europe PMC9 |
| 2020 | Galletly, C. (2020). A Whale of an issue.. Aust N Z J Psychiatry, 54(11), 1053-1055. |
| 2020 | Yolland, C. O. B., Phillipou, A., Castle, D. J., Neill, E., Hughes, M. E., Galletly, C., . . . Rossell, S. L. (2020). Improvement of cognitive function in schizophrenia with N-acetylcysteine: a theoretical review. Nutritional Neuroscience, 23(2), 139-148. Scopus41 WoS35 Europe PMC31 |
| 2020 | Cai, H. Q., Catts, V. S., Webster, M. J., Galletly, C., Liu, D., O Donnell, M., . . . Weickert, C. S. (2020). Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation. Molecular Psychiatry, 25(4), 761-775. Scopus189 WoS182 Europe PMC166 |
| 2020 | Wong, K. T. G., Liu, D., Balzan, R., King, D., & Galletly, C. (2020). Smartphone and Internet Access and Utilization by People With Schizophrenia in South Australia: Quantitative Survey Study.. JMIR mental health, 7(1), e11551. Scopus21 WoS19 Europe PMC17 |
| 2020 | Zulfic, Z., Weickert, C. S., Weickert, T. W., Liu, D., Myles, N., & Galletly, C. (2020). Neutrophil-lymphocyte ratio - a simple, accessible measure of inflammation, morbidity and prognosis in psychiatric disorders?. Australas Psychiatry, 28(4), 454-458. Scopus43 WoS39 Europe PMC34 |
| 2020 | Myles, H., Myles, N., Vincent, A. D., Wittert, G., Adams, R., Chandratilleke, M., . . . Galletly, C. (2020). Pilot cohort study of obstructive sleep apnoea in community-dwelling people with schizophrenia.. Ir J Psychol Med, 38(1), 1-7. Scopus5 WoS7 Europe PMC5 |
| 2020 | Galletly, C. (2020). Psychiatry in the COVID-19 Era. Australian and New Zealand Journal of Psychiatry, 54(5), 447-448. Scopus21 Europe PMC15 |
| 2020 | Siskind, D., Northwood, K., Berk, M., Castle, D., Galletly, C., & Harris, A. (2020). Monitoring for post-injection delirium/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic. Australian and New Zealand Journal of Psychiatry, 54(7), 759-761. Scopus2 Europe PMC2 |
| 2020 | Cai, H. Q., Weickert, T. W., Catts, V. S., Balzan, R., Galletly, C., Liu, D., . . . Shannon Weickert, C. (2020). Altered levels of immune cell adhesion molecules are associated with memory impairment in schizophrenia and healthy controls. Brain, Behavior, and Immunity, 89, 200-208. Scopus29 WoS27 Europe PMC25 |
| 2020 | Clifford, L., Crabb, S., Turnbull, D., Hahn, L., & Galletly, C. (2020). A qualitative study of medication adherence amongst people with schizophrenia. Archives of Psychiatric Nursing, 34(4), 194-199. Scopus28 WoS25 Europe PMC18 |
| 2020 | Plevin, D., & Galletly, C. (2020). The neuropsychiatric effects of vitamin C deficiency: a systematic review.. BMC Psychiatry, 20(1), 1-9. Scopus98 WoS76 Europe PMC59 |
| 2020 | Thomson, S., Doan, T., Liu, D., Schubert, K. O., Toh, J., Boyd, M. A., & Galletly, C. (2020). Supporting the vulnerable: developing a strategic community mental health response to the COVID-19 pandemic. Australasian Psychiatry, 28(5), 492-499. Scopus14 WoS14 Europe PMC13 |
| 2020 | Galletly, C. (2020). Sexual misconduct by doctors: a problem that has not gone away. Medical Journal of Australia, 213(5), 216-217. Scopus2 WoS3 |
| 2020 | Henderson, S., Berk, M., Boyce, P., Jorm, A., Galletly, C., Porter, R., . . . Malhi, G. (2020). Finding reviewers: A crisis for journals and their authors. Australian and New Zealand Journal of Psychiatry, 54(10), 957-959. Scopus6 WoS3 Europe PMC2 |
| 2019 | Balzan, R. P., Mattiske, J. K., Delfabbro, P., Liu, D., & Galletly, C. (2019). Individualized Metacognitive Training (MCT+) Reduces Delusional Symptoms in Psychosis: A Randomized Clinical Trial.. Schizophrenia bulletin, 45(1), 27-36. Scopus35 WoS33 Europe PMC27 |
| 2019 | Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., . . . Stubbs, B. (2019). The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness. The Lancet Psychiatry, 6(8), 675-712. Scopus1285 WoS1221 Europe PMC1043 |
| 2019 | Firth, J., Rosenbaum, S., Galletly, C., Siddiqi, N., Stubbs, B., Killackey, E., . . . Siskind, D. (2019). Protecting physical health in people with mental illness – Authors' reply. The Lancet Psychiatry, 6(11), 890-891. Scopus19 WoS8 Europe PMC9 |
| 2019 | Galletly, C. (2019). More access for some but not others: Is it better?. Australian and New Zealand Journal of Psychiatry, 53(11), 1041-1043. Scopus1 Europe PMC1 |
| 2019 | Szabo, S., Lloyd, B., McKellar, D., Myles, H., Newton, H., Schutz, J., . . . Galletly, C. (2019). ‘Having a mentor helped me with difficult times’: a trainee-run mentoring project. Australasian Psychiatry, 27(3), 230-233. Scopus14 WoS14 Europe PMC7 |
| 2019 | Galletly, C. A., & Xinhui, L. (2019). To suit the occasion, I wore my fancy dress.. Australasian Psychiatry. |
| 2019 | Szabo, S., Lloyd, B., McKellar, D., Newton, H., Shutz, J., Hahn, L., & Galletly, C. (2019). 'Having a mentor helped me with difficult times:' a trainee-run mentoring project.. Australasian Psychiatry, 27(3), 230-233. |
| 2019 | Balzan, R., Delfabbro, P., Mattiske, J., Liu, D., & Galletly, C. (2019). Individualized Metacognitive Training (MCT+) Reduces Delusional Symptoms in Psychosis: A randomised Clinical Trial.. Schizophrenia Bulletin, 45(1), 27-36. |
| 2019 | Galletly, C. (2019). Paracetamol, pregnancy and public health. Australian and New Zealand Journal of Psychiatry, 53(3), 181-183. |
| 2019 | Myles, N., Myles, H., Xia, S., Large, M., Bird, R., Galletly, C., . . . Siskind, D. (2019). A meta-analysis of controlled studies comparing the association between clozapine and other antipsychotic medications and the development of neutropenia. Australian and New Zealand Journal of Psychiatry, 53(5), 403-412. Scopus71 WoS64 Europe PMC52 |
| 2019 | Lim, X., & Galletly, C. (2019). “To suit the occasion, I wore my schizophrenic fancy dress” – the life of Janet Frame. Australasian Psychiatry, 27(5), 1039856219839489. Scopus2 WoS1 |
| 2019 | Clarke, E., Clarke, P., Gill, S., Paterson, T., Hahn, L., & Galletly, C. (2019). Efficacy of repetitive transcranial magnetic stimulation in the treatment of depression with comorbid anxiety disorders.. Journal of affective disorders, 252, 435-439. Scopus61 WoS51 Europe PMC43 |
| 2019 | Owens, S. J., Weickert, T. W., Purves-Tyson, T. D., Ji, E., White, C., Galletly, C., . . . Shannon Weickert, C. (2019). Sex-Specific Associations of Androgen Receptor CAG Trinucleotide Repeat Length and of Raloxifene Treatment with Testosterone Levels and Perceived Stress in Schizophrenia.. Molecular neuropsychiatry, 5(1), 28-41. Europe PMC2 |
| 2019 | Weickert, C. S., Lee, C. H., Lenroot, R. K., Bruggemann, J., Galletly, C., Liu, D., . . . Weickert, T. W. (2019). Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophrenia. Schizophrenia Research, 209, 212-217. Scopus14 WoS14 Europe PMC12 |
| 2019 | Lee, C. H., Sinclair, D., O'Donnell, M., Galletly, C., Liu, D., Weickert, C. S., & Weickert, T. W. (2019). Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder. Schizophrenia Research, 213, 87-95. Scopus16 WoS15 Europe PMC9 |
| 2019 | Kindler, J., Lim, C. K., Weickert, C. S., Boerrigter, D., Galletly, C., Liu, D., . . . Weickert, T. W. (2019). Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia. Molecular Psychiatry, 43(11), 13 pages. Scopus231 WoS219 Europe PMC202 |
| 2019 | Turner, S., Harvey, C., Hayes, L., Castle, D., Galletly, C., Sweeney, S., . . . Spittal, M. J. (2019). Childhood adversity and clinical and psychosocial outcomes in psychosis. Epidemiology and Psychiatric Sciences, 29, e78. Scopus56 WoS50 Europe PMC33 |
| 2019 | Myles, H., Myles, N., Coetzer, C. L. C., Adams, R., Chandratilleke, M., Liu, D., . . . Galletly, C. (2019). Cognition in schizophrenia improves with treatment of severe obstructive sleep apnoea: a pilot study. Schizophrenia Research: Cognition, 15, 14-20. Scopus20 WoS17 Europe PMC14 |
| 2018 | Hahn, L., Mackinnon, A., Foley, D., Morgan, V., Waterreus, A., Watts, G., . . . Galletly, C. (2018). Counting up the risks: How common are risk factors for morbidity and mortality in young people with psychosis?. Early Intervention in Psychiatry: the development, onset and treatment of emerging mental disorders, 12(6), 1045-1051. Scopus8 WoS7 Europe PMC6 |
| 2018 | Wong, K. T. G., Liu, D., Balzan, R., King, D., & Galletly, C. (2018). Smartphone and Internet Access and Utilization by People With Schizophrenia in South Australia: Quantitative Survey Study (Preprint). |
| 2018 | Galletly, C., & Myles, H. (2018). Making an impact. Australian and New Zealand Journal of Psychiatry, 52(8), 725-726. Scopus1 Europe PMC1 |
| 2018 | Jacomb, I., Stanton, C., Vasudevan, R., Powell, H., O'Donnell, M., Lenroot, R., . . . Weickert, T. (2018). C-Reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls. Frontiers in Immunology, 9(OCT), 2230-1-2230-16. Scopus93 WoS88 Europe PMC87 |
| 2018 | Rosenich, E., Gill, S., Clarke, P., Paterson, T., Hahn, L., & Galletly, C. (2018). Does rTMS reduce depressive symptoms in young people who have not responded to antidepressants?. Early Intervention in Psychiatry, 13(5), 1-7. Scopus19 WoS14 Europe PMC14 |
| 2018 | Galletly, C., Suetani, S., & Dark, F. (2018). Medication discontinuation in first episode psychosis: thinking about the offset of psychotic disorders. Australian and New Zealand Journal of Psychiatry, 52(9), 819-821. Scopus3 WoS3 Europe PMC1 |
| 2018 | Haeney, O., Ash, D., & Galletly, C. (2018). School Shootings – ‘It wouldn’t happen here’?. Australian and New Zealand Journal of Psychiatry, 52(5), 405-407. Scopus2 WoS2 Europe PMC1 |
| 2018 | Myles, H., Vincent, A., Myles, N., Adams, R., Chandratilleke, M., Liu, D., . . . Galletly, C. (2018). Obstructive sleep apnoea is more prevalent in men with schizophrenia compared to general population controls: results of a matched cohort study. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 26(6), 600-603. Scopus20 WoS14 Europe PMC12 |
| 2018 | Myles, N., Myles, H., Xia, S., Large, M., Kisely, S., Galletly, C., . . . Siskind, D. (2018). Meta-analysis examining the epidemiology of clozapine-associated neutropenia. Acta psychiatrica Scandinavica, 138(2), 101-109. Scopus193 Europe PMC142 |
| 2018 | Balzan, R. P., Dhillon, V. S., Liu, D., Hahn, L., Fenech, M. F., & Galletly, C. (2018). Shorter telomere length in people with schizophrenia who live alone?. Schizophrenia Research, 199, 422-423. Scopus6 WoS4 Europe PMC3 |
| 2018 | Campbell, L., Hanlon, M. -C., Galletly, C., Harvey, C., Stain, H., Cohen, M., . . . Brown, S. (2018). Severity of illness and adaptive functioning predict quality of care of children among parents with psychosis: A confirmatory factor analysis. Australian and New Zealand Journal of Psychiatry, 52(5), 435-445. Scopus25 WoS26 Europe PMC20 |
| 2018 | Koblar, S., Cranwell, M., Koblar, S., Carnell, B., & Galletly, C. (2018). Developing empathy: does experience through simulation improve medical student empathy?. Medical Science Educator, 28(1), 31-36. Scopus17 |
| 2017 | Boerrigter, D., Weickert, T., Lenroot, R., O'Donnell, M., Galletly, C., Liu, D., . . . Weickert, C. (2017). Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder. Journal of Neuroinflammation, 14(1), 188-1-188-15. Scopus149 WoS145 Europe PMC132 |
| 2017 | Galletly, C. A. (2017). Psychiatry training: survive and thrive. Medical Journal of Australia, 206(11), 485. |
| 2017 | Galletly, C. (2017). Risks, benefits and finding the best way forward. Australian and New Zealand Journal of Psychiatry, 51(10), 963-964. |
| 2017 | Castle, D. J., Galletly, C. A., Dark, F., Humberstone, V., Morgan, V. A., Killackey, E., . . . Jablensky, A. (2017). The 2016 Royal Australian and New Zealand College of Psychiatrists guidelines for the management of schizophrenia and related disorders. Medical Journal of Australia, 206(11), 501-505. Scopus25 WoS26 Europe PMC21 |
| 2017 | Glass, L., Sinclair, D., Boerrigter, D., Naude, K., Fung, S., Brown, D., . . . Shannon Weickert, C. (2017). Brain antibodies in the cortex and blood of people with schizophrenia and controls. Translational Psychiatry, 7(8), 1-9. Scopus19 WoS20 Europe PMC18 |
| 2017 | Jablensky, A., Castle, D. J., Dark, F., Humberstone, V., Killackey, E., Kulkarni, J., . . . Galletly, C. (2017). The 2016 RANZCP Guidelines for the Management of Schizophrenia and Related Disorders – what’s next?. Australasian Psychiatry, 25(6), 600-602. Scopus7 WoS7 Europe PMC7 |
| 2017 | Groenkjaer, M., de Crespigny, C., Liu, D., Moss, J., Cairney, I., Lee, D., . . . Galletly, C. (2017). "The chicken or the egg": barriers and facilitators to collaborative care for people with comorbidity in a metropolitan region of South Australia. Issues in Mental Health Nursing, 38(1), 18-24. Scopus14 WoS13 Europe PMC12 |
| 2017 | Galletly, C. A., Carnell, B. L., Clarke, P., & Gill, S. (2017). A comparison of right unilateral and sequential bilateral repetitive transcranial magnetic stimulation for major depression: a naturalistic clinical Australian study. Journal of ECT, 33(1), 58-62. Scopus11 WoS11 Europe PMC8 |
| 2017 | Myles, N., Large, M., Myles, H., Adams, R., Liu, D., & Galletly, C. (2017). Australia's economic transition, unemployment, suicide and mental health needs. Australian and New Zealand Journal of Psychiatry, 51(2), 119-123. Scopus15 WoS13 Europe PMC12 |
| 2017 | Allison, S., Bastiampillai, T., Galletly, C., & Nance, M. (2017). An Australian collaborative research network: Building the evidence for inpatient psychiatry.. Australian and New Zealand Journal of Psychiatry, 51(8), 1. |
| 2017 | Galletly, C. (2017). Premature death in schizophrenia: bridging the gap. The Lancet Psychiatry, 4(4), 263-265. Scopus24 WoS21 Europe PMC18 |
| 2017 | Hahn, L. A., Mackinnon, A., Foley, D. L., Morgan, V. A., Waterreus, A., Watts, G. F., . . . Galletly, C. A. (2017). The role of arterial elasticity and cardiovascular peripheral resistance as clinically relevant indices of health status in people with psychosis. Schizophrenia Research, 184, 88-95. Scopus3 WoS3 Europe PMC1 |
| 2017 | Morgan, V., Waterreus, A., Carr, V., Castle, D., Cohen, M., Harvey, C., . . . Galletly, C. (2017). Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis. Australian and New Zealand Journal of Psychiatry, 51(2), 124-140. Scopus104 WoS94 Europe PMC72 |
| 2017 | Smith, C., Myles, H., & Galletly, C. (2017). Developing a metformin prescribing tool for use in adults with mental illness to reduce medication-related weight gain and cardiovascular risk. Australasian Psychiatry, 25(4), 387-390. Scopus4 WoS4 Europe PMC3 |
| 2017 | Carnell, B. L., Clarke P., Gill, S., Galletly, C. A., & Galletly, C. A. (2017). How effective is repetitive Transcranial Magnetic Stimulation for Bipolar Depression?. The Journal of Affective Disorders, 209, 270-272. Scopus19 WoS16 Europe PMC14 |
| 2017 | Galletly, C., Dhillon, V. S., Liu, D., Balzan, R. P., Hahn, L. A., & Fenech, M. F. (2017). Shorter telomere length in people with schizophrenia: a preliminary study from Australia. Schizophrenia Research, 190, 46-51. Scopus19 WoS18 Europe PMC18 |
| 2017 | Posselt, M., McDonald, K., Procter, N., De Crespigny, C., & Galletly, C. (2017). Improving the provision of services to young people from refugee backgrounds with comorbid mental health and substance use problems: addressing the barriers. BMC Public Health, 17(1), 280-1-280-17. Scopus52 WoS51 Europe PMC31 |
| 2017 | Large, M., Galletly, C., Myles, N., Ryan, C. J., & Myles, H. (2017). Known unknowns and unknown unknowns in suicide risk assessment: Evidence from meta-analyses of aleatory and epistemic uncertainty. Bjpsych Bulletin, 41(3), 160-163. Scopus34 Europe PMC20 |
| 2017 | Nielssen, O., McGorry, P., Castle, D., & Galletly, C. (2017). The RANZCP guidelines for Schizophrenia: why is our practice so far short of our recommendations, and what can we do about it?. Australian and New Zealand Journal of Psychiatry, 51(7), 670-674. Scopus7 WoS6 Europe PMC7 |
| 2017 | Siskind, D., Harris, M., Phillipou, A., Morgan, V., Waterreus, A., Galletly, C., . . . Castle, D. (2017). Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis. Epidemiology and psychiatric sciences, 26(3), 325-337. Scopus27 WoS25 Europe PMC25 |
| 2017 | Hahn, L., Mackinnon, A., Foley, D., Morgan, V., Waterreus, A., Watts, G., . . . Galletly, C. (2017). The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosis. Schizophrenia Research, 182, 13-18. Scopus3 WoS3 Europe PMC2 |
| 2017 | Kulkarni, J., & Galletly, C. A. (2017). Improving safety for women in psychiatry wards. Australian and New Zealand Journal of Psychiatry, 51(2), 192-194. Scopus11 WoS8 Europe PMC10 |
| 2017 | Myles, H., Myles, N., Liu, D., Adams, R., Wittert, G., Antic, N. A., & Galletly, C. (2017). How long will we sleep on obstructive sleep apnoea in schizophrenia?. Australian & New Zealand Journal of Psychiatry, 51(1), 95-96. Scopus3 WoS3 Europe PMC2 |
| 2016 | Large, M., Galletly, C. A., Myles, N., Ryan, C. J., & Myles, H. (2016). Known unknown and unknown unknowns in Suicide Risk Assessment: Aleatory and Epistemic uncertainty. BJPsych Bulletin. |
| 2016 | Weinberg, D., Lenroot, R., Jacomb, I., Allen, K., Bruggemann, J., Wells, R., . . . Weickert, T. (2016). Cognitive subtypes in schizophrenia characterized by differential brain volumetric reductions and cognitive decline. JAMA Psychiatry, 73(12), 1251-1259. Scopus88 WoS86 Europe PMC79 |
| 2016 | Liu, D., Myles, H., Foley, D., Watts, G., Morgan, V., Castle, D., . . . Galletly, C. (2016). Risk factors for obstructive sleep apnea are prevalent in people with psychosis and correlate with impaired social functioning and poor physical health. Frontiers in Psychiatry, 7(AUG), 139-1-139-12. Scopus18 WoS13 Europe PMC9 |
| 2016 | Morgan, V., Morgan, F., Galletly, C., Valuri, G., Shah, S., & Jablensky, A. (2016). Sociodemographic, clinical and childhood correlates of adult violent victimisation in a large, national survey sample of people with psychotic disorders. Social Psychiatry and Psychiatric Epidemiology, 51(2), 269-279. Scopus23 WoS20 Europe PMC19 |
| 2016 | Myles, H., Myles, N., Antic, N., Adams, R., Chandratilleke, M., Liu, D., . . . Galletly, C. (2016). Obstructive sleep apnea and schizophrenia: a systematic review to inform clinical practice. Schizophrenia Research, 170(1), 222-225. Scopus67 WoS53 Europe PMC46 |
| 2016 | Galletly, C., Clark, L., McFarlane, A., Searle, A., Sawyer, M., Sim, M., . . . van Hooff, M. (2016). Childhood lead exposure, childhood trauma, substance use and subclinical psychotic experiences - a longitudinal cohort study. Psychiatry Research, 239, 54-61. Scopus5 WoS5 |
| 2016 | Galletly, C., Turnbull, C., & Goldney, R. (2016). Medical student teaching in the private sector - An overlooked opportunity?. Australasian Psychiatry, 24(2), 198-200. Scopus4 WoS3 Europe PMC2 |
| 2016 | Galletly, C. A., Gill, S., Rigby, A., Carnell, B. L., & Clarke, P. (2016). Assessing the effects of repetitive transcranial magnetic stimulation on cognition in major depressive disorder using computerized cognitive testing. Journal of ECT, 32(3), 169-173. Scopus12 WoS11 Europe PMC9 |
| 2016 | Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., . . . Tran, N. (2016). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry, 50(5), 410-472. Scopus765 WoS700 Europe PMC544 |
| 2016 | Foley, D., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A., & Galletly, C. (2016). Awareness of pre-diabetes or diabetes and associated factors in people with psychosis. Schizophrenia Bulletin, 42(5), 1280-1289. Scopus13 WoS11 Europe PMC6 |
| 2016 | Liu, D., de Crespigny, C., Procter, N., Kelly, J., Francis, H., Posselt, M., . . . Galletly, C. A. (2016). Comorbidity action in the north – a study of services for people with comorbid mental health and drug and alcohol disorders in the northern suburbs of Adelaide. Australasian Psychiatry, 24(6), 592-597. Scopus12 WoS12 Europe PMC9 |
| 2016 | Suetani, S., Waterreus, A., Morgan, V., Foley, D., Galletly, C., Badcock, J., . . . McGrath, J. (2016). Correlates of physical activity in people living with psychotic illness. Acta Psychiatrica Scandinavica, 134(2), 129-137. Scopus45 WoS39 Europe PMC36 |
| 2016 | Cohen, O., Weickert, T., Hess, J., Paish, L., McCoy, S., Rothmond, D., . . . Glatt, S. (2016). A splicing-regulatory polymorphism in DRD2 disrupts ZRANB2 binding, impairs cognitive functioning and increases risk for schizophrenia in six Han Chinese samples. Molecular Psychiatry, 21(7), 975-982. Scopus32 WoS23 Europe PMC24 |
| 2016 | Galletly, C. (2016). Compulsive reading: Stars with addictions, to Star Wars. Australian and New Zealand Journal of Psychiatry, 50(8), 713-715. |
| 2016 | Waterreus, A., Di Prinzio, P., Watts, G., Castle, D., Galletly, C., & Morgan, V. (2016). Metabolic syndrome in people with a psychotic illness: Is cannabis protective?. Psychological Medicine, 46(8), 1651-1662. Scopus22 Europe PMC20 |
| 2016 | Foley, D., Mackinnon, A., Morgan, V., Castle, D., Waterreus, A., Galletly, C., & Galletly, C. (2016). Comorbid Diabetes and Depression in a National Sample of Adults With Psychosis. Schizophrenia Bulletin, 44(1), 9 pages. Scopus15 WoS12 Europe PMC11 |
| 2016 | Sweeney, S., Air, T., Zannettino, L., Shah, S. S., & Galletly, C. (2016). Corrigendum: Gender differences in the physical and psychological manifestation of childhood trauma and/or adversity in people with psychosis [Front. Psychol, 6, (2015):(1768)] Doi: 10.3389/fpsyg.2015.01768. Frontiers in Psychology, 7(AUG), 2 pages. Scopus1 WoS2 Europe PMC1 |
| 2016 | Rossell, S., Francis, P., Galletly, C., Harris, A., Siskind, D., Berk, M., . . . Castle, D. (2016). N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms. BMC Psychiatry, 16(1), 320-1-320-9. Scopus39 WoS32 Europe PMC29 |
| 2016 | Large, M., Galletly, C., Myles, N., Ryan, C., & Myles, H. (2016). Known unknown and unknown unknowns in suicide risk assessment: what do recent meta-analyses tell us about aleatory and epistemic uncertainty?. BJ Psych Bulletin, 1-4. |
| 2016 | Galletly, C. A. (2016). Look who's talking. Aust N Z J Psychiatry, 50(11), 1031-1032. |
| 2016 | Pillai, A., Howell, K., Ahmed, A., Weinberg, D., Allen, K., Bruggemann, J., . . . Weickert, T. (2016). Association of serum VEGF levels with prefrontal cortex volume in schizophrenia. Molecular Psychiatry, 21(5), 686-692. Scopus73 WoS66 Europe PMC62 |
| 2016 | Foley, D., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A., & Galletly, C. (2016). Common familial risk factors for schizophrenia and diabetes mellitus. Australian and New Zealand Journal of Psychiatry, 50(5), 488-494. Scopus25 WoS22 Europe PMC18 |
| 2015 | Happell, B., Galletly, C., Castle, D., Platania-Phung, C., Stanton, R., Scott, D., . . . Furness, T. (2015). Scoping review of research in Australia on the co-occurrence of physical and serious mental illness and integrated care. International Journal of Mental Health Nursing, 24(5), 421-438. Scopus15 WoS16 Europe PMC13 |
| 2015 | Balzan, R., & Galletly, C. (2015). Metacognitive therapy (MCT+) in patients with psychosis not receiving antipsychotic medication: a case study. Frontiers in Psychology, 6, 967-1-967-6. Scopus14 WoS11 Europe PMC8 |
| 2015 | Posselt, M., Procter, N., de Crespigny, C., & Galletly, C. (2015). Merging perspectives: obstacles to recovery for youth from refugee backgrounds with comorbidity. Australasian Psychiatry, 23(3), 293-299. Scopus18 WoS17 Europe PMC10 |
| 2015 | Weickert, T., Weinberg, D., Lenroot, R., Catts, S., Wells, R., Vercammen, A., . . . Weickert, C. (2015). Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia. Molecular Psychiatry, 20(6), 685-694. Scopus123 WoS118 Europe PMC108 |
| 2015 | Happell, B., Platania-Phung, C., Webster, S., McKenna, B., Millar, F., Stanton, R., . . . Scott, D. (2015). Applying the World Health Organization Mental Health Action Plan to evaluate policy on addressing co-occurrence of physical and mental illnesses in Australia. Australian Health Review, 39(4), 370-378. Scopus12 WoS12 Europe PMC10 |
| 2015 | Kisely, S., Chang, A., Crowe, J., Galletly, C., Jenkins, P., Loi, S., . . . Macfarlane, S. (2015). Getting started in research: Systematic reviews and meta-analyses. Australasian Psychiatry, 23(1), 16-21. Scopus9 Europe PMC4 |
| 2015 | Lacey, M., Paolini, S., Hanlon, M., Melville, J., Galletly, C., & Campbell, L. (2015). Parents with serious mental illness: differences in internalised and externalised mental illness stigma and gender stigma between mothers and fathers. Psychiatry Research, 225(3), 723-733. Scopus43 WoS43 Europe PMC31 |
| 2015 | Clarke, P., Gill, S., Carnell, B., & Galletly, C. (2015). How safe is repetitive Transcranial Magnetic Stimulation?. Australian and New Zealand Journal of Psychiatry, 49(5), 485. Scopus7 WoS5 Europe PMC3 |
| 2015 | Ford, N., Ludbrook, G., & Galletly, C. (2015). Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression. Australian and New Zealand Journal of Psychiatry, 49(12), 1227. Scopus22 WoS19 Europe PMC17 |
| 2015 | Suetani, S., Gill, S., & Galletly, C. (2015). A scholarly endeavour: Some practical tips on completing the scholarly project. Australasian Psychiatry, 23(1), 29-31. Scopus10 WoS10 Europe PMC9 |
| 2015 | Galletly, C. A., Loo, C. K., Malhi, G. S., Mitchell, P. B., & Fitzgerald, P. (2015). Why repetitive transcranial magnetic stimulation should be available for treatment resistant depression. Australian and New Zealand Journal of Psychiatry, 49(2), 182-183. Scopus1 WoS1 |
| 2015 | Nenke, M., Hahn, L., Thompson, C., Liu, D., & Galletly, C. (2015). Psychosis and cardiovascular disease: Is diet the missing link?. Schizophrenia Research, 161(2-3), 465-470. Scopus18 WoS16 Europe PMC12 |
| 2015 | Foley, D., Mackinnon, A., Morgan, V., Watts, G., Shaw, J., Magliano, D., . . . Galletly, C. (2015). Cardiovascular risk factor associations in adults with psychosis and adults in a national comparator sample. The Australian and New Zealand Journal of Psychiatry, 49(8), 714-723. Scopus11 WoS8 Europe PMC11 |
| 2015 | Cairney, I., Galletly, C., de Crespigny, C., Liu, D., Moss, J., & Procter, N. (2015). Stopping the run-around? A study of services for people with comorbid mental health and substance use disorders in northern Adelaide. Australasian Psychiatry, 23(3), 233-235. Scopus4 WoS3 Europe PMC3 |
| 2015 | Posselt, M., Procter, N., Galletly, C., & de Crespigny, C. (2015). Aetiology of coexisting mental health and alcohol and other drug disorders: perspectives of refugee youth and service providers. Australian Psychologist, 50(2), 130-140. Scopus32 WoS30 |
| 2015 | Galletly, C. (2015). Let there be light .... Australian and New Zealand Journal of Psychiatry, 49(3), 201-202. |
| 2015 | Foley, D., Mackinnon, A., Morgan, V., Watts, G., Castle, D., Waterreus, A., & Galletly, C. (2015). Effect of age, family history of diabetes, and antipsychotic drug treatment on risk of diabetes in people with psychosis: a population-based cross-sectional study. The Lancet Psychiatry, 2(12), 1092-1098. Scopus28 WoS25 Europe PMC18 |
| 2015 | Galletly, C. A. (2015). Making things better?. Australian and New Zealand Journal of Psychiatry, 49(11), 958-959. |
| 2015 | Galletly, C., Clarke, P., Carnell, B., & Gill, S. (2015). A clinical repetitive transcranial magnetic stimulation service in Australia: 6 years on. Australian and New Zealand Journal of Psychiatry, 49(11), 1040-1047. Scopus19 WoS14 Europe PMC9 |
| 2015 | Badcock, J., Shah, S., Mackinnon, A., Stain, H., Galletly, C., Jablensky, J., & Morgan, V. (2015). Loneliness in psychotic disorders and its association with cognitive function and symptom profile. Schizophrenia Research, 169(1-3), 268-273. Scopus141 WoS132 Europe PMC108 |
| 2015 | Galletly, C. A. (2015). ANZJP Weltanschauung. Australian and New Zealand Journal of Psychiatry, 49(8), 677-678. |
| 2015 | de Crespigny, C., Groenkjaer, M., Liu, D., Moss, J., Cairney, I., Procter, N., . . . Galletly, C. (2015). Service provider barriers to treatment and care for people with mental health and alcohol and other drug comorbidity in a metropolitan region of South Australia. Advances in Dual Diagnosis, 8(3), 120-128. Scopus16 WoS17 |
| 2015 | Sweeney, S., Air, T., Zannettino, L., & Galletly, C. (2015). Psychosis, socioeconomic disadvantage, and health service use in South Australia: Findings from the second. Frontiers in Public Health, 3, 1-8. Scopus32 Europe PMC22 |
| 2015 | Sweeney, S., Air, T., Zannettino, L., & Galletly, C. (2015). Gender differences in the physical and psychological manifestation of childhood trauma and/or adversity in people with psychosis. Frontiers in Psychology, 6(NOV), 1768-1-1768-8. Scopus45 WoS42 Europe PMC34 |
| 2014 | Gill, S., Clarke, P., Rigby, A., Carnell, B., & Galletly, C. (2014). Transcranial Magnetic Stimulation and psychological therapies: Considering the benefits of a combined treatment approach for depression. World Journal of Medical Research, 3(7), 46-53. |
| 2014 | Galletly, C. A. (2014). Educating psychiatrists in the post-pharma era. Andhra Pradesh Journal of Psychological Medicine, 15(1), 10-12. |
| 2014 | Shah, S., Mackinnon, A., Galletly, C., Carr, V., McGrath, J., Stain, H., . . . Morgan, V. (2014). Prevalence and impact of childhood abuse in people with a psychotic illness. Data from the second Australian national survey of psychosis. Schizophrenia Research, 159(1), 20-26. Scopus32 WoS30 Europe PMC27 |
| 2014 | Morgan, V., McGrath, J., Jablensky, A., Badcock, J., Waterreus, A., Bush, R., . . . MacKinnon, A. (2014). Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Psychological Medicine, 44(10), 2163-2176. Scopus172 WoS168 Europe PMC127 |
| 2014 | Hahn, L., Galletly, C., Foley, D., Mackinnon, A., Watts, G., Castle, D., . . . Morgan, V. (2014). Inadequate fruit and vegetable intake in people with psychosis. Australian and New Zealand Journal of Psychiatry, 48(11), 1025-1035. Scopus41 WoS40 Europe PMC34 |
| 2014 | Chan, W., Batterham, P., Christensen, H., & Galletly, C. (2014). Suicide literacy, suicide stigma and help-seeking intentions in Australian medical students. Australasian Psychiatry, 22(2), 132-139. Scopus97 WoS90 Europe PMC71 |
| 2014 | Balzan, R. P., Neaves, A., Denson, L. A., Liu, D., & Galletly, C. (2014). Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between?. Cognitive Neuropsychiatry, 19(6), 471-484. Scopus26 WoS26 Europe PMC20 |
| 2014 | Searle, A., Baghurst, P., van Hooff, M., Sawyer, M., Sim, M., Galletly, C., . . . McFarlane, A. (2014). Tracing the long-term legacy of childhood lead exposure: a review of three decades of the Port Pirie Cohort study. NeuroToxicology, 43, 46-56. Scopus51 WoS43 Europe PMC35 |
| 2014 | Foley, D., MacKinnon, A., Morgan, V., Watts, G., McGrath, J., Castle, D., . . . Galletly, C. (2014). Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis. World Psychiatry, 13(2), 176-183. Scopus29 WoS31 Europe PMC28 |
| 2014 | Galletly, C., Clarke, P., Paterson, T., Rigby, A., & Gill, S. (2014). Practical considerations in the use of ultrabrief ECT in clinical practice. Journal of ECT, 30(1), 10-14. Scopus26 WoS20 Europe PMC16 |
| 2014 | Posselt, M., Galletly, C., de Crespigny, C., Cairney, I., Moss, J., Liu, D., . . . Banders, A. (2014). Ethics overload: impact of excessive ethical review on comorbidity research. Mental Health and Substance Use, 7(3), 184-194. Scopus6 |
| 2014 | Posselt, M., Galletly, C., de Crespigny, C., & Procter, N. (2014). Mental health and drug and alcohol comorbidity in young people of refugee background: a review of the literature. Mental Health and Substance Use, 7(1), 19-30. Scopus32 |
| 2014 | Galletly, C. (2014). Should lithium be added to the drinking water?. Australian & New Zealand Journal of Psychiatry, 48(9), 793-794. |
| 2014 | Ashton, M., Rigby, A., & Galletly, C. (2014). Do population-wide tobacco control approaches help smokers with mental illness?. Australian & New Zealand Journal of Psychiatry, 48(2), 121-123. Scopus14 WoS12 Europe PMC7 |
| 2014 | Burton, C., Gill, S., Clarke, P., & Galletly, C. (2014). Maintaining remission of depression with repetitive transcranial magnetic stimulation during pregnancy: a case report. Archives of Women's Mental Health, 17(3), 247-250. Scopus16 WoS13 Europe PMC10 |
| 2014 | Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2014). Metacognitive training for patients with schizophrenia: preliminary evidence for a targeted, single module programme. Australian and New Zealand Journal of Psychiatry, 48(12), 1126-1136. Scopus54 WoS49 Europe PMC38 |
| 2014 | Hahn, L., Rigby, A., & Galletly, C. (2014). Determinants of high rates of smoking among people with psychosis living in a socially disadvantaged region in South Australia. Australian and New Zealand Journal of Psychiatry, 48(1), 70-79. Scopus20 WoS19 Europe PMC18 |
| 2013 | Galletly, C. (2013). When the body attacks the brain. Australian and New Zealand Journal of Psychiatry, 47(12), 1099-1100. |
| 2013 | Tidswell, J., Kleinig, T., Ash, D., Thompson, P., & Galletly, C. (2013). Early recognition of anti-N-methyl D-aspartate (Nmda) receptor encephalitis presenting as acute psychosis. Australasian Psychiatry, 21(6), 596-599. Scopus12 WoS10 Europe PMC10 |
| 2013 | Galletly, C., & Rigby, A. (2013). An overview of cognitive remediation therapy for people with severe mental illness. ISRN Rehabilitation, 2013, 1-6. |
| 2013 | McFarlane, A., Searle, A., Van Hooff, M., Baghurst, P., Sawyer, M., Galletly, C., . . . Clark, L. (2013). Prospective associations between childhood low-level lead exposure and adult mental health problems: The port pirie cohort study. Neurotoxicology, 39, 11-17. Scopus32 WoS33 Europe PMC25 |
| 2013 | Galletly, C. (2013). Sunshine, supplements, CBT and more. Australian and New Zealand Journal of Psychiatry, 47(3), 199-200. |
| 2013 | Altree, T., & Galletly, C. (2013). Laxative use and altered drug absorption. Australian and New Zealand Journal of Psychiatry, 47(7), 686. Scopus3 WoS2 Europe PMC1 |
| 2013 | Ashton, M., Rigby, A., & Galletly, C. (2013). What do 1000 smokers with mental illness say about their tobacco use?. Australian and New Zealand Journal of Psychiatry, 47(7), 631-636. Scopus34 WoS30 Europe PMC26 |
| 2013 | Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2013). Illusory correlations and control across the psychosis continuum: the contribution of hypersalient evidence-hypothesis matches. Journal of Nervous and Mental Disease, 201(4), 319-327. Scopus25 WoS23 Europe PMC18 |
| 2013 | Ashton, M., Mulconray, S., Weston, M., Rigby, A., & Galletly, C. (2013). Peer workers' role in smoking-cessation groups for people with mental illness. Australasian Psychiatry, 21(3), 246-248. Scopus5 WoS7 Europe PMC7 |
| 2013 | Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2013). Confirmation biases across the psychosis continuum: The contribution of hypersalient evidence-hypothesis matches. British Journal of Clinical Psychology, 52(1), 53-69. Scopus55 WoS53 Europe PMC39 |
| 2013 | Ashton, M., Rigby, A., & Galletly, C. (2013). Evaluation of a community-based smoking cessation programme for people with severe mental illness. Tobacco Control, 24(3), 275-280. Scopus21 WoS20 Europe PMC14 |
| 2013 | Foley, D., Mackinnon, A., Watts, G., Shaw, J., Magliano, D., Castle, D., . . . Galletly, C. (2013). Cardiometabolic risk Indicators that distinguish adults with psychosis from the general population, by age and gender. PLoS One, 8(12), 1-8. Scopus41 WoS41 Europe PMC35 |
| 2012 | Hall, T., Galletly, C., Clark, C., Veltmeyer, M., Metzger, L., Gilbertson, M., . . . McFarlane, A. (2012). The relationship between Hippocampal asymmetry and working memory processing in combat-related PTSD: a monozygotic twin study. Biology of Mood & Anxiety Disorders, 2(21), 1-8. Europe PMC7 |
| 2012 | Galletly, C., Neaves, A., Burton, C., Liu, D., & Denson, L. (2012). Evaluating health literacy in people with mental illness using the Test of Functional Health Literacy in Adults. Nursing Outlook, 60(5), 316-321. Scopus20 WoS19 Europe PMC14 |
| 2012 | Campbell, L., Hanlon, M., Poon, A., Paolini, S., Stone, M., Galletly, C., . . . Cohen, M. (2012). The experiences of Australian parents with psychosis: the second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 890-900. Scopus65 WoS58 Europe PMC37 |
| 2012 | Stain, H., Galletly, C., Clark, S., Wilson, J., Killen, E., Anthes, L., . . . Harvey, C. (2012). Understanding the social costs of psychosis: the experience of adults affected by psychosis identified within the second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 879-889. Scopus152 WoS140 Europe PMC105 |
| 2012 | Moore, E., Mancuso, S., Slade, T., Galletly, C., & Castle, D. (2012). The impact of alcohol and illicit drugs on people with psychosis: the Second Australian National Survey of Psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 864-878. Scopus64 WoS58 Europe PMC45 |
| 2012 | Cooper, J., Mancuso, S., Borland, R., Slade, T., Galletly, C., & Castle, D. (2012). Tobacco smoking among people living with a psychotic illness: the second Australian survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(9), 851-863. Scopus145 WoS136 Europe PMC120 |
| 2012 | Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2012). Reasoning heuristics across the psychosis continuum: the contribution of hypersalient evidence-hypothesis matches. Cognitive Neuropsychiatry, 17(5), 431-450. Scopus29 WoS28 Europe PMC20 |
| 2012 | Waterreus, A., Morgan, V., Castle, D., Galletly, C., Jablensky, A., Di Prinzio, P., & Shah, S. (2012). Medication for psychosis - consumption and consequences: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 762-773. Scopus53 WoS51 Europe PMC46 |
| 2012 | Galletly, C., Foley, D., Waterreus, A., Watts, G., Castle, D., McGrath, J., . . . Morgan, V. (2012). Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 753-761. Scopus176 WoS167 Europe PMC142 |
| 2012 | Waghorn, G., Saha, S., Harvey, C., Morgan, V., Waterreus, A., Bush, R., . . . McGrath, J. (2012). 'Earning and learning' in those with psychotic disorders: the second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 774-785. Scopus110 WoS103 Europe PMC79 |
| 2012 | Morgan, V., Waterreus, A., Jablensky, A., Mackinnon, A., McGrath, J., Carr, V., . . . Saw, S. (2012). People living with psychotic illness in 2010: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46(8), 735-752. Scopus435 WoS364 Europe PMC341 |
| 2012 | Ash, D., Singh, T., Air, T., Burton, C., & Galletly, C. (2012). Metabolic health of people admitted to a psychiatric intensive care unit in Adelaide, South Australia. Primary Care Companion to the Journal of Clinical Psychiatry, 14(1), 1-2. |
| 2012 | Balzan, R., Delfabbro, P., Galletly, C., & Woodward, T. (2012). Over-adjustment or miscomprehension? A re-examination of the jumping to conclusions bias. Australian and New Zealand Journal of Psychiatry, 46(6), 532-540. Scopus69 WoS69 Europe PMC56 |
| 2012 | Balzan, R., Delfabbro, P., & Galletly, C. (2012). Delusion-proneness or miscomprehension? A re-examination of the jumping-to-conclusions bias. Australian Journal of Psychology, 64(2), 100-107. Scopus23 WoS25 |
| 2012 | Kelly, D., Gill, S., Clarke, P., Burton, C., & Galletly, C. (2012). Delayed response to repetitive transcranial magnetic stimulation treatment for intractable auditory hallucinations in schizoaffective disorder. Annals of Clinical Psychiatry, 24(2), 172-173. Scopus4 WoS1 Europe PMC1 |
| 2012 | Forbes, F., Galletly, C., Liu, D., Tyllis, P., & Clark, C. (2012). Assessing cognition in schizophrenia: a comparison of clinician and computerized test administration. Applied Neuropsychology, 19(0001), 9-15. Scopus4 WoS3 Europe PMC4 |
| 2012 | Galletly, C., Paterson, T., & Burton, C. (2012). A report on the introduction of ultrabrief pulse width ECT in a private psychiatric hospital. Journal of ECT, 28(1), 59. Scopus12 WoS10 Europe PMC4 |
| 2012 | Galletly, C., Gill, S., Clarke, P., Burton, C., & Fitzgerald, P. (2012). A randomized trial comparing repetitive transcranial magnetic stimulation given 3 days/week and 5 days/week for the treatment of major depression: Is efficacy related to the duration of treatment or the number of treatments?. Psychological Medicine, 42(5), 981-988. Scopus46 WoS41 Europe PMC39 |
| 2012 | Galletly, C. (2012). Debates, disputes, discussions and deliberations. Australian and New Zealand Journal of Psychiatry, 46(10), 917-918. |
| 2012 | Dawson, S., Kettler, L., Burton, C., & Galletly, C. (2012). Do people with schizophrenia lack emotional intelligence?. Schizophrenia Research and Treatment, Online, 1-8. WoS15 Europe PMC12 |
| 2012 | Silverstein, S., All, S., Thompson, J., Williams, L., Whitford, T., Nagy, M., . . . Gordon, E. (2012). Absolute level of gamma synchrony is increased in first-episode schizophrenia during face processing. Journal of Experimental Psychopathology, 3(4), 702-723. Scopus5 WoS5 |
| 2012 | Galletly, C. (2012). People living with psychosis: the good news and the bad news. Australian and New Zealand Journal of Psychiatry, 46(9), 803-807. Scopus6 WoS4 Europe PMC4 |
| 2012 | Galletly, C., Clark, L., Van Hooff, M., & McFarlane, A. (2012). CHILDHOOD TRAUMA AND SUBCLINICAL PSYCHOTIC EXPERIENCES IN YOUNG ADULTHOOD: 20-YEAR LONGITUDINAL ANALYSES OF TWO COHORT STUDIES. SCHIZOPHRENIA RESEARCH, 136, S63-S64. WoS1 |
| 2012 | Galletly, C. A., de Crespigny, C., Athanasos, P., Moss, J., Proctor, N., Banders, A., . . . Francis, H. (2012). COMORBIDITY ACTION RESEARCH IN NORTHERN ADELAIDE, SOUTH AUSTRALIA. SCHIZOPHRENIA RESEARCH, 136, S276. |
| 2012 | Galletly, C. A., Foley, D. L., Waterreus, A., Watts, G. F., Castle, D., McGrath, J., . . . Morgan, V. A. (2012). HIGH RATES OF CARDIOMETABOLIC RISK FACTORS IN PEOPLE WITH PSYCHOTIC DISORDERS. SCHIZOPHRENIA RESEARCH, 136, S308. |
| 2011 | Galletly, C. A. (2011). Differential diagnosis of Tardive Dyskinesia in an elderly woman taking antipsychotic medication. Annals of Clinical Psychiatry, 23(4), 308-309. |
| 2011 | Galletly, C., Van Hooff, M., & McFarlane, A. (2011). PSYCHOTIC SYMPTOMS IN YOUNG ADULTS EXPOSED TO BUSHFIRES DURING CHILDHOOD - A 20 YEAR FOLLOW-UP STUDY. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 45, A34. |
| 2011 | Galletly, C., Van Hooff, M., & McFarlane, A. (2011). Psychotic symptoms in young adults exposed to childhood trauma - A 20 year follow-up study. Schizophrenia Research, 127(1-3), 76-82. Scopus54 WoS54 Europe PMC42 |
| 2011 | Galletly, C., Bell, S., Burton, C., & Turnbull, C. (2011). Bed accessibility in a private psychiatric hospital. Australasian Psychiatry, 19(2), 160-162. Scopus2 WoS2 |
| 2011 | Galletly, C., & Burton, C. (2011). Improving medical student attitudes towards people with schizophrenia. Australian and New Zealand Journal of Psychiatry, 45(6), 473-476. Scopus57 WoS54 Europe PMC35 |
| 2011 | Galletly, C. (2011). ANZJP This Month. Australian and New Zealand Journal of Psychiatry, 45(12), 1015-1016. |
| 2011 | Crismani, C., & Galletly, C. (2011). 'Walk-ins': Developing a nursing role to manage unscheduled presentations to a community mental health clinic. Contemporary Nurse, 39(1), 12-19. Scopus2 WoS2 Europe PMC1 |
| 2011 | Galletly, C., & Crichton, J. (2011). Accomplishments of the thought disordered person: A case study in psychiatrist-patient interaction. Medical Hypotheses, 77(5), 900-904. Scopus4 WoS3 Europe PMC1 |
| 2010 | Singh, R., Rowan, J., Burton, C., & Galletly, C. (2010). How effective is a hospital at home service for people with acute mental illness?. Australasian Psychiatry, 18(6), 512-516. Scopus13 WoS15 Europe PMC8 |
| 2010 | Galletly, C., Fitzgerald, P., Clarke, P., Gill, S., Burton, C., & Turnbull, C. (2010). A practical guide to setting up a repetitive transcranial magnetic stimulation (rTMS) service. Australasian Psychiatry, 18(4), 314-317. Scopus8 WoS8 Europe PMC7 |
| 2010 | Galletly, C. A. (2010). Ask patients about their internet use. Medical Journal of Australia, 193(5), 312. Scopus2 WoS1 Europe PMC1 |
| 2009 | Ash, D., & Galletly, C. (2009). Challenges in psychiatric classification: The case of generalized anxiety disorder. Australasian Psychiatry, 17(6), 484-487. Scopus1 |
| 2009 | Galletly, C., Chur-Hansen, A., Air, T., & Chapman, I. (2009). Academics of the future? A survey of final year medical students. Australasian Psychiatry, 17(6), 502-505. Scopus10 WoS9 Europe PMC9 |
| 2009 | Harvey, K., Galletly, C., Field, C., & Proeve, M. (2009). The effects of verbalisation on cognitive performance in schizophrenia: A pilot study using tasks from Delis Kaplan Executive Function System. Neuropsychological Rehabilitation, 19(5), 733-741. Scopus12 WoS10 Europe PMC9 |
| 2009 | Alexander, D., Flynn, G., Wong, W., Whitford, T., Harris, A., Galletly, C., & Silverstein, S. (2009). Spatio-temporal EEG waves in first episode schizophrenia. Clinical Neurophysiology, 120(9), 1667-1682. Scopus27 WoS28 Europe PMC27 |
| 2009 | Clark, C., Galletly, C., Ash, D., Moores, K., Penrose, R., & McFarlane, A. (2009). Evidence-based medicine evaluation of electrophysiological studies of the anxiety disorders. Clinical EEG and Neuroscience, 40(2), 84-112. Scopus58 WoS46 Europe PMC38 |
| 2009 | Galletly, C. (2009). Recent advances in treating cognitive impairment in schizophrenia. Psychopharmacology, 202(1-3), 259-273. Scopus43 WoS30 Europe PMC28 |
| 2009 | Galletly, C., & Burton, C. (2009). The effects of experiencing simulated auditory hallucinations on attitudes to schizophrenia in final year medical students. Proceedings of 2nd Biennial Schizophrenia International Research Conference, 117(2-3), 402-403. WoS1 |
| 2008 | Flynn, G., Alexander, D., Harris, A., Whitford, T., Wong, W., Galletly, C., . . . Williams, L. (2008). Increased absolute magnitude of gamma synchrony in first-episode psychosis. Schizophrenia Research, 105(1-3), 262-271. Scopus63 WoS59 Europe PMC50 |
| 2008 | Nestor, P., & Galletly, C. (2008). The employment of consumers in mental health services: politically correct tokenism or genuinely useful?. Australasian Psychiatry, 16(5), 344-347. Scopus29 WoS28 Europe PMC20 |
| 2008 | Savilla, K., Kettler, L., & Galletly, C. (2008). Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Australian and New Zealand Journal of Psychiatry, 42(6), 496-504. Scopus101 WoS88 Europe PMC75 |
| 2008 | Galletly, C., McFarlane, A., & Clark, C. (2008). Differentiating cortical patterns of cognitive dysfunction in schizophrenia and posttraumatic stress disorder. Psychiatry Research, 159(1-2), 196-206. Scopus9 WoS9 Europe PMC10 |
| 2008 | Williams, L., Whitford, T., Flynn, G., Wong, W., Liddell, B., Silverstein, S., . . . Gordon, E. (2008). General and social cognition in first episode schizophrenia: Identification of separable factors and prediction of functional outcome using the IntegNeuro, test battery. Schizophrenia Research, 99(1-3), 182-191. Scopus97 WoS82 Europe PMC73 |
| 2008 | Edwards, B., Galletly, C., Semmler-Booth, T., & Dekker, G. (2008). Does antenatal screening for psychosocial risk factors predict postnatal depression? A follow-up study of 154 women in Adelaide, South Australia. Australian and New Zealand Journal of Psychiatry, 42(1), 51-55. Scopus47 WoS42 Europe PMC37 |
| 2008 | Edwards, B., Galletly, C., Semmler-Booth, T., & Dekker, G. (2008). Antenatal psychosocial risk factors and depression amoung women living in socioeconomically disadvantaged suburbs in Adelaide, South Australia. Australian and New Zealand Journal of Psychiatry, 42(1), 45-50. Scopus53 WoS48 Europe PMC43 |
| 2008 | Keks, N., Galletly, C. A., Hope, J., & Hustig, H. (2008). Management of acute psychosis in an emergency setting. Advances in Schizophrenia and Clinical Psychiatry, 3, 78`-83. |
| 2007 | Galletly, C. A., McFarlane, A. C., & Clark, C. R. (2007). Erratum to "Impaired updating of working memory in schizophrenia" [International Journal of Psychophysiology 63 (2007) 265-274] (DOI:10.1016/j.ijpsycho.2006.11.004). International Journal of Psychophysiology, 66(3), 271. |
| 2007 | Plevin, D., Galletly, C., & Roughan, P. (2007). Sexual dysfunction in men treated with depot antipsychotic drugs: A pilot study. Sexual Health, 4(4), 269-271. Scopus6 WoS7 Europe PMC3 |
| 2007 | Galletly, C., Moran, L., Noakes, M., Clifton, P., Tomlinson, L., & Norman, R. (2007). Psychological benefits of a high-protein low-carbohydrate diet in obese women with polycystic ovary syndrome - A pilot study. Appetite, 49(3), 590-593. Scopus87 WoS74 Europe PMC66 |
| 2007 | Galletly, C., McFarlane, A., & Clark, C. (2007). Impaired updating of working memory in schizophrenia. International Journal of Psychophysiology, 63(3), 265-274. Scopus28 WoS24 Europe PMC18 |
| 2006 | Galletly, C., & Watson, D. (2006). Substance misuse in patients with acute mental illness. Medical Journal of Australia, 184(12), 645. Scopus1 WoS1 Europe PMC1 |
| 2006 | Brown, K., Alexander, D., Boord, P., Das, P., Flynn, G., Galletly, C., . . . Williams, L. (2006). Reduced fMRI activity in response to salient stimuli in first-episode schizophrenia.. Acta neuropsychiatrica, 18(6), 279-280. |
| 2006 | Galletly, C., Proeve, M., Field, C., & Harvey, K. (2006). Silence is golden? Improving cognitive performance in schizophrenia.. Acta neuropsychiatrica, 18(6), 251. |
| 2006 | Das, P., Alexander, D., Boord, P., Brown, K., Flynn, G., Galletly, C., . . . Wong, W. (2006). Impaired connectivity in amygdala pathways may explain disorganization symptoms of patients with first-episode schizophrenia.. Acta neuropsychiatrica, 18(6), 282. Europe PMC1 |
| 2006 | Alexander, D., Boord, P., Brown, K., Das, P., Flynn, G., Galletly, C., . . . Wong, W. (2006). First-episode psychosis and direction of wave propagation at 1 Hz in the EEG.. Acta neuropsychiatrica, 18(6), 240. Europe PMC3 |
| 2005 | Galletly, C., Clark, C., & McFarlane, A. (2005). Clozapine improves working memory updating in schizophrenia. European Neuropsychopharmacology, 15(6), 601-608. Scopus17 WoS16 Europe PMC13 |
| 2004 | Galletly, C. (2004). Crossing professional boundaries in medicine: the slippery slope to patient sexual exploitation. Medical Journal of Australia, 181(7), 380-383. Scopus56 WoS45 Europe PMC24 |
| 2004 | Moran, L., Noakes, M., Clifton, P., Wittert, G., Tomlinson, L., Galletly, C., . . . Norman, R. (2004). Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. Journal of Clinical Endocrinology and Metabolism, 89(7), 3337-3344. Scopus150 WoS121 Europe PMC100 |
| 2004 | Moran, L. J., Noakes, M., Clifton, P. M., Tomlinson, L., Galletly, C., & Norman, R. J. (2004). Erratum: Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome (Journal of Clinical Endocrinology and Metabolism (2003) 88 (812-819)). Journal of Clinical Endocrinology and Metabolism, 89(5), 2337. |
| 2003 | Ash, D., Galletly, C., Haynes, J., & Braben, P. (2003). Violence, self-harm, victimisation and homelessness in patients admitted to an acute inpatient unit in South Australia. International Journal of Social Psychiatry, 49(2), 112-118. Scopus19 Europe PMC14 |
| 2003 | Moran, L., Noakes, M., Clifton, P., Tomlinson, L., & Norman, R. (2003). Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 88(2), 812-819. Scopus449 WoS361 Europe PMC290 |
| 2001 | Galletly, C., Clark, C., McFarlane, A., & Weber, D. (2001). Working memory in posttraumatic stress disorder - An event-related potential study. Journal of Traumatic Stress, 14(2), 295-309. Scopus73 WoS64 Europe PMC56 |
| 2000 | Comley, C., Galletly, C., & Ash, D. (2000). The use of atropine eye drops for clozapine induced hypersalivation. Australian and New Zealand Journal of Psychiatry, 34(6), 1033-1034. |
| 2000 | Galletly, C. (2000). Psychiatry and fertility services. Australasian Psychiatry, 8(3), 264-266. |
| 2000 | Galletly, C., Clark, C., & McFarlane, A. (2000). Treating cognitive dysfunction in patients with schizophrenia. Journal of Psychiatry & Neuroscience, 25(2), 117-124. Scopus19 WoS19 Europe PMC14 |
| 2000 | Galletly, C. A., Clark, C. R., McFarlane, A. C., & Weber, D. L. (2000). The effect of clozapine on the speed and accuracy of information processing in schizophrenia. Progress in Neuro Psychopharmacology and Biological Psychiatry, 24(8), 1329-1338. Scopus26 WoS24 Europe PMC16 |
| 2000 | Galletly, C. (2000). Correspondence. Australasian Psychiatry, 8(3), 264-265. |
| 2000 | Comley, C., Galletly, C., & Ash, D. (2000). Use of atropine eye drops for clozapine induced hypersalivation [5]. Australian and New Zealand Journal of Psychiatry, 34(6), 1033-1034. Scopus43 Europe PMC29 |
| 1999 | Galletly, C. (1999). Prescribing of psychotropic drugs in an acute inpatient unit. Australian and New Zealand Journal of Psychiatry, 33(2), 181-182. Scopus5 Europe PMC3 |
| 1999 | Galletly, C., Clark, C., McFarlane, A., & Weber, D. (1999). Effects of Clozapine for Non-Treatment-Resistant Patients with Schizophrenia. Psychiatric Services, 50(1), 101-103. Scopus16 WoS13 Europe PMC12 |
| 1999 | Ash, D., Galletly, C., Kinneally, J., & Braben, P. (1999). Self-Reported Forensic Histories Among Patients Admitted to an Acute Psychiatric Unit. Psychiatry, Psychology and Law, 6(2), 197-202. Scopus1 |
| 1998 | Clark, A., Thornley, B., Tomlinson, L., Galletly, C., & Norman, R. (1998). Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Human Reproduction, 13(6), 1502-1505. Scopus630 WoS494 Europe PMC365 |
| 1998 | Galletly, C., & Whyte, F. (1998). Epidemiology of prostate cancer in two European countries: Scotland and Norway. European Journal of Cancer Care, 7(4), 240-246. |
| 1997 | Galletly, C. (1997). Borderline-dissociation comorbidity [8]. American Journal of Psychiatry, 154(11), 1629. Scopus7 Europe PMC2 |
| 1997 | Galletly, C. A., & Tsourtos, G. (1997). Antipsychotic drug doses and adjunctive drugs in the outpatient treatment of schizophrenia. Annals of Clinical Psychiatry, 9(2), 77-80. Scopus12 Europe PMC9 |
| 1997 | Galletly, C. A. (1997). Dissociation and PTSD. American Journal of Psychiatry, 154, 1629. |
| 1997 | Field, C., Galletly, C., Anderson, D., & Walker, P. (1997). Computer aided cognitive rehabilitation possible application to the attentional deficit of schizophrenia, a report of negative results. Perceptual and Motor Skills, 85(3, part 1), 995-1002. Scopus32 Europe PMC18 |
| 1997 | Galletly, C., Clark, R., McFarlane, A., & Lueber, D. (1997). Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine.. Psychiatry Research, 72, 159-161. |
| 1997 | Galletly, C. (1997). Clinical rating scales for substance abuse. Psychiatric Services, 48(1), 105-106. |
| 1997 | Galletly, C., & Tsourtos, G. (1997). Antipsychotic drug doses in the outpatient treatment of schizophrenia. Annals of Clinical Psychiatry, 9(2), 77-80. |
| 1997 | Galletly, C. (1997). Borderline-Dissociation Comorbidity. American Journal of Psychiatry, 154, 629. |
| 1997 | Ash, D., & Galletly, C. (1997). Crisis beds: The interface between the hospital and the community. International Journal of Social Psychiatry, 43(3), 193-198. Scopus9 Europe PMC5 |
| 1997 | Galletly, C. A., Clark, C. R., McFarlane, A. C., & Weber, D. L. (1997). Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine. Psychiatry Research, 72(3), 161-166. Scopus108 WoS91 Europe PMC72 |
| 1996 | Galletly, C. A., Clark, C. R., & McFarlane, A. C. (1996). Artificial neural networks and psychiatric disorders. BRITISH JOURNAL OF PSYCHIATRY, 169(6), 793-794. WoS1 Europe PMC1 |
| 1996 | 118. McFarlane, A. C., Clark, C. R., Weber, D., & Galletly, C. A. (1996). Biological paradigms of the attentional processing in post traumatic stress disorder. European Neuropsychopharmacology, 6, 80. |
| 1996 | Galletly, C., Clark, A., & Tomlinson, L. (1996). Evaluation of dexfenfluramine in a weight loss program for obese infertile women.. International Journal of Eating Disorders, 19(2), 209-212. Scopus11 Europe PMC6 |
| 1996 | Galletly, C., Clark, A., Tomlinson, L., & Blaney, F. (1996). Improved pregnancy rates for obese, infertile women following a group treatment program: an open pilot study. General Hospital Psychiatry, 18(3), 192-195. Scopus51 Europe PMC24 |
| 1996 | Galletly, C. (1996). Comment on "Sexual Abuse in therapy : gender issues.". Australian and New Zealand Journal of Psychiatry, 30, 132-133. |
| 1996 | Galletly, C. (1996). Subjective muscle weakness and hypotnoia during Clozapine treatment. Annals of Clinical Psychiatry, 8(4), 189-192. Scopus7 Europe PMC6 |
| 1996 | Galletly, C., Clark, A., Tomlinson, L., & Blaney, F. (1996). A group program for obese, infertile women: weight loss and improved psychological health. Journal of Psychosomatic Obstetrics and Gynaecology, 17(2), 125-128. Scopus39 Europe PMC25 |
| 1996 | Galletly, C., Clark, C., & McFarlane, A. (1996). Artificial Neural Networks: A prospective tool for the analysis of psychiatric disorders.. Journal of Psychiatry and Neuroscience, 21(4), 239-247. Scopus15 WoS10 Europe PMC5 |
| 1996 | Galletly, C., Wilson, D., & McEwen, S. (1996). Eosiniphilia associated with decreasing neutrophil count in a Clozapine-treated patient.. Journal of Clinical Psychiatry, 57, 40-41. Scopus4 Europe PMC28 |
| 1996 | Galletly, C. A., Clark, C. R., & McFarlane, A. C. (1996). Artificial neural networks and psychiatric disorders.. British Journal of Psychiatry the Journal of Mental Science, 169(6), 793-794. Scopus1 |
| 1996 | Galletly, C. (1996). Comment. Australian and New Zealand Journal of Psychiatry, 30(1), 132-133. |
| 1995 | Clark, A., Ledger, W., Galletly, C., Tomlinson, L., Blaney, F., Wang, X., & Norman, R. (1995). Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Human Reproduction, 10(10), 2705-2712. Scopus558 WoS405 Europe PMC292 |
| 1995 | Galletly, C. A., Schrader, G. D., Chestemtan, H. M., & Tsourtos, G. (1995). Medical student attitudes to psychiatry: lack of effect of psychiatric hospital experience. Medical Education, 29(6), 449-451. Scopus44 WoS34 Europe PMC20 |
| 1993 | 123. Burnett, P. L., Galletly, C. A., Moyle, R. J., & Clark, R. (1993). A review of the efficacy of low-dose antipsychotic medication in the treatment of schizophrenia. Schizophrenia Bulletin, 19, 155-164. |
| 1993 | Burnett, P. L., Galletly, C. A., Moyle, R. J., & Clark, C. R. (1993). Low-dose depot medication in schizophrenia. Schizophrenia Bulletin, 19(1), 155-164. Scopus15 WoS17 Europe PMC9 |
| 1993 | Galletly, C. A. (1993). Psychiatrist-patient sexual relationships: The ethical dilemmas. Australasian Psychiatry, 27(1), 133-139. Scopus17 WoS14 Europe PMC11 |
| 1993 | Galletly, C. A., Field, C. D., & Prior, M. (1993). Urine drug screening of patients admitted to a state psychiatric hospital. Hospital and Community Psychiatry, 44(6), 587-589. Scopus28 WoS25 Europe PMC15 |
| 1992 | Galletly, C. A. (1992). Antipsychotic drug doses in a schizophrenia inpatient unit. Australian and New Zealand Journal of Psychiatry, 26(4), 574-576. Scopus17 WoS15 Europe PMC8 |
| 1991 | Galletly, C. A., Field, C. D., & Ormond, C. L. (1991). Changing patterns of electroconvulsive therapy use: Results of a five-year survey. Australian and New Zealand Journal of Psychiatry, 25(4), 535-540. Scopus9 WoS9 Europe PMC7 |
| 1991 | Galletly, C. A. (1991). A review of antipsychotic drug doses.. Australian Clinical Review Australian Medical Association and the Australian Council on Hospital Standards, 11, 74-76. |
| 1987 | Galletly, C. A., Field, C., & Ormond, C. (1987). An audit of electroconvulsive therapy.. Australian Clinical Review Australian Medical Association and the Australian Council on Hospital Standards, 7(27), 171-174. Scopus1 Europe PMC1 |
| 1987 | Galletly, C. A., & Field, C. D. (1987). Learning and memory impairment with benzhexol. Australian and New Zealand Journal of Psychiatry, 21(4), 612-614. Scopus4 WoS5 Europe PMC3 |
| 1985 | Galletly, C. A., Morris, H., & Newcombe, A. (1985). The dexamethasone suppression test in elderly, non-depressed patients with dementia. Australian and New Zealand Journal of Psychiatry, 19(1), 95-96. Scopus3 WoS2 Europe PMC3 |
| 1983 | 131. Morris, H. A., Gilliland, J. M., Berriman, H. E., & Galletly, C. A. (1983). Assessment of the dexamethasone suppression test of endogenous depression. Clinical Biochemical Research, 4, 82. |
| 1982 | Manley, D., & Galletly, C. A. (1982). Survey of children and their families presenting at a child psychiatric service. New Zealand Medical Journal, 95(718), 732-734. |
| 1982 | James, B., & Galletly, C. A. (1982). The psychiatric contribution to general medical education: Some problems of generalization. Medical Education, 16(3), 147-150. Scopus1 Europe PMC1 |
| 1979 | Franzcp, B. J., & Galletly, C. A. (1979). Case notes as indicators of the prevailing medical model: Implications. New Zealand Medical Journal, 90(648), 427-431. |
| 1979 | Galletly, C., & James, B. (1979). Anorexia nervosa in a male: Comment and illustration. New Zealand Medical Journal, 89(631), 171-173. Scopus2 Europe PMC1 |
| - | Galletly, C. (2014). Role of cognitive enhancement in schizophrenia. Neuroscience and Neuroeconomics, 75. |
| Year | Citation |
|---|---|
| 2019 | Galletly, C., & McFarlane, A. S. (2019). Memory disturbances in schizophrenia and posttraumatic stress disorder. In A. Moskowitz, I. Schäfer, & M. Dorahy (Eds.), Psychosis, Trauma and Dissociation: Evolving Perspectives on Severe Psychopathology (2nd revised ed., pp. 271-282). NJ; USA: John Wiley & Sons. DOI |
| 2016 | Ashton, M., Carnell, B. L., & Galletly, C. (2016). Smokers with Severe Mental Illness. In V. R. Preedy (Ed.), Neuropathology of Drug Addictions and Substance Misuse (Vol. 1, pp. 254-259). London; United Kingdom: Academic Press. DOI |
| 2013 | Galletly, C., Lincoln, A., & Arford, T. (2013). Health literacy and people with mental illness. In R. Moore, & D. Perry (Eds.), Health Literacy: Developments, Issues and Outcomes (1 ed., pp. 143-158). United States: Nova Science Publishers. |
| 2008 | Galletly, C. A. (2008). Working Memory in Schizophrenia. In N. Johansen (Ed.), New Research on Short Term Memory. Hauppauge. New York: Nova Science Publishers. |
| Year | Citation |
|---|---|
| 2019 | Weickert, T., Jacomb, I., Lenroot, R., Lappin, J., Weinberg, D., Brooks, W., . . . Weickert, C. S. (2019). REDUCTION IN PERIPHERAL C-REACTIVE PROTEIN LEVELS WITH CANAKINUMAB ADMINISTRATION IS RELATED TO REDUCED POSITIVE SYMPTOM SEVERITY IN PATIENTS WITH SCHIZOPHRENIA AND INFLAMMATION. In SCHIZOPHRENIA BULLETIN Vol. 45 (pp. S318). Orlando, FL: OXFORD UNIV PRESS. DOI WoS6 |
| 2018 | Balzan, R., Delfabbro, P., Galletly, C., Mattiske, J., & McLean, B. (2018). Metacognitive Therapy (MCT plus ) for psychosis. In AUSTRALIAN PSYCHOLOGIST Vol. 53 (pp. 5). WILEY. |
| 2018 | Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., . . . Nga, T. (2018). THE ROYAL AUSTRALIAN AND NEW ZEALAND CLINICAL PRACTICE GUIDELINES FOR SCHIZOPHRENIA AND RELATED DISORDERS (2016) - A STEP TOWARDS BETTER CARE?. In SCHIZOPHRENIA BULLETIN Vol. 44 (pp. S214). Florence, ITALY: OXFORD UNIV PRESS. DOI WoS2 |
| 2018 | Wong, K. T. G., King, D., Balzan, R., Liu, D., & Galletly, C. (2018). TECHNOLOGY LITERACY AND ENGAGEMENT IN PEOPLE WITH SCHIZOPHRENIA. In SCHIZOPHRENIA BULLETIN Vol. 44 (pp. S208). Florence, ITALY: OXFORD UNIV PRESS. DOI WoS1 |
| 2018 | Weickert, T., Cai, H., O'Donnell, M., Balzan, R., Wells, R., Liu, D., . . . Weickert, C. S. (2018). ICAM-1 IS INCREASED IN BRAIN AND PERIPHERAL LEVELS OF SOLUBLE ICAM-1 IS RELATED TO COGNITIVE DEFICITS IN SCHIZOPHRENIA. In SCHIZOPHRENIA BULLETIN Vol. 44 (pp. S73-S74). Florence, ITALY: OXFORD UNIV PRESS. DOI WoS2 |
| 2018 | Thomson, S., Galletly, C., Prener, C., Garverich, S., Liu, D., & Lincoln, A. (2018). HEALTH LITERACY IN PEOPLE WITH SCHIZOPHRENIA ATTENDING COMMUNITY MENTAL HEALTH CLINICS. In SCHIZOPHRENIA BULLETIN Vol. 44 (pp. S137). Florence, ITALY: OXFORD UNIV PRESS. DOI WoS1 |
| 2016 | Myles, H., Antic, N. A., Adams, R., Chandratilleke, M., Liu, D., Myles, N., . . . Galletly, C. (2016). CLOZAPINE: THE DOUBLE-EDGED SWORD - A WORKSHOP ON THE QUALITY AND SAFE USE OF CLOZAPINE. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 50 (pp. 17). SAGE PUBLICATIONS LTD. |
| 2014 | Morgan, V. A., Badcock, J., Waterreus, A., Galletly, C., Shah, S., & Mackinnon, A. (2014). THE ROLE OF COGNITION IN METABOLIC DISTURBANCE IN PEOPLE WITH PSYCHOTIC ILLNESS: NOVEL DATA FROM A LARGE POPULATION PREVALENCE SURVEY. In SCHIZOPHRENIA RESEARCH Vol. 153 (pp. S223-S224). ELSEVIER SCIENCE BV. DOI |
| 2014 | Galletly, C., Hahn, L., Foley, D., McKinnon, A., Watts, G., Castle, D., . . . Morgan, V. A. (2014). DETERMINANTS OF POOR DIET AMONG A LARGE SAMPLE OF PEOPLE LIVING WITH A PSYCHOTIC ILLNESS. In SCHIZOPHRENIA RESEARCH Vol. 153 (pp. S316). ELSEVIER SCIENCE BV. DOI |
| 2014 | Galletly, C., Lincoln, A., Burton, C., Arford, T., Prener, C., & Liu, D. (2014). LIMITED LITERACY AMONG PEOPLE WITH SERIOUS MENTAL ILLNESS IN THE US AND AUSTRALIA: A NATURAL EXPERIMENT?. In SCHIZOPHRENIA RESEARCH Vol. 153 (pp. S121-S122). ELSEVIER SCIENCE BV. DOI |
| 2014 | Galletly, C., Foley, D. L., Mackinnon, A., Watts, G. F., Shaw, J., Magliano, D., . . . Morgan, V. A. (2014). RISK FACTORS FOR DEATH AND DISABILITY IN YOUNG PEOPLE WITH PSYCHOSIS. In SCHIZOPHRENIA RESEARCH Vol. 153 (pp. S19-S20). ELSEVIER SCIENCE BV. DOI |
| 2014 | Waterreus, A., Di Prinzio, P., Galletly, C., Castle, D. J., Watts, G., & Morgan, V. A. (2014). METABOLIC SYNDROME IN PEOPLE WITH PSYCHOSIS: IS CANNABIS PROTECTIVE?. In SCHIZOPHRENIA RESEARCH Vol. 153 (pp. S381). ELSEVIER SCIENCE BV. DOI |
| 2010 | Balzan, R., Delfabbro, P., & Galletly, C. (2010). HOW HYPOTHESIS-CONFIRMING AND HYPOTHESIS-DISCONFIRMING INFORMATION IS TREATED ACROSS THE PSYCHOSIS CONTINUUM. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 44 (pp. A35). INFORMA HEALTHCARE. |
| 2010 | Galletly, C., Silverstein, S., Huby, A., Williams, L., & Harris, A. (2010). COGNITION IN RECENT ONSET SCHIZOPHRENIA. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 44 (pp. A41). INFORMA HEALTHCARE. |
| 2010 | Galletly, C., Neaves, A., Burton, C., Liu, D., & Denson, L. (2010). Health literacy in schizophrenia and depression. In Proceedings of 11th Australasian schizophrenia conference 2010 Vol. 44 (pp. 0 pages). INFORMA HEALTHCARE. DOI |
| 2009 | Galletly, C., Clarke, L., Legg, J., James, L., Connor, J., & Air, T. (2009). Assessing the quality of the first episode psychosis services in Adelaide. In ANZ Journal of Psychiatry (pp. 27). |
| 2009 | Clark, L., Galletly, C., Legg, L., James, L., Connor, J., & Air, T. (2009). Substance Use in Young People with First Episode Psychosis in Adelaide. In Australian & New Zealand Journal of Psychiatry Vol. 43 (pp. 0 pages). UK: You need to add a publisher. DOI |
| 2009 | Clarke, P., Gill, S., & Galletly, C. (2009). PRELIMINARY REPORT COMPARING TRANSCRANIAL MAGNETIC STIMULATION DELIVERED THREE TIMES PER WEEK VERSUS FIVE TIMES PER WEEK. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 43 (pp. A5). SAGE PUBLICATIONS LTD. |
| 2009 | Galletly, C. (2009). SCHIZOPHRENIA SYMPOSIUM RECENT RESEARCH IN SCHIZOPHRENIA - WHAT DO WE REALLY KNOW?. In AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY Vol. 43 (pp. A9). SAGE PUBLICATIONS LTD. |
| 2005 | Edwards, B., Semmler-Booth, T., Galletly, C., & Dekker, G. (2005). Detecting risk for depression at first antenatal visit. In Australian and New Zealand Journal of Psychiatry Vol. 39 (pp. A113-A114). Blackwell Publishing Asia. DOI |
| 2004 | Galletly, C. A., McFarlane, A., & Clark, R. (2004). Clozapine improves cerebral indices of working memory function in schizophrenia. In INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY Vol. 7 (pp. S403). Paris, FRANCE: CAMBRIDGE UNIV PRESS. |
| 2003 | Moran, L., Noakes, M., Clifton, P., Wittert, G., Tomlinson, L., Galletly, C., . . . Norman, R. (2003). Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition.. In Asia Pacific journal of clinical nutrition Vol. 12 Suppl (pp. S52). Australia. Europe PMC2 |
| 2000 | Galletly, C., Clark, C., McFarlane, A., & Weber, D. (2000). The effects of treatment with Clozapine on ERP indices of working memory in schizophrenia. In Sidney Bloch (Ed.), Abstracts for the 35th Annual Congress - Looking Outward: Culture, Creativity & Psychiatry Vol. 34 (pp. A25). Victoria, Australia: Blackwell Science Asia. DOI |
| Year | Citation |
|---|---|
| 2023 | Schubert, K. O., Pathirana, M., FUGARO, P., Onf, H., Fenech, D., GUIDOLIN, M., . . . Wright, S. (2023). EXTERNAL AND SERVICE FACTORS INFLUENCING OUTCOMES IN A MODEL OF STRATIFIED MENTAL HEALTH SERVICES FOR YOUNG PEOPLE. Poster session presented at the meeting of International Conference on Early Intervention 14. Luscerne, Switzerland. |
| 2022 | Clark, S., Mills, N., Toben, C., Catharine, J., & Galletly, C. (2022). Evaluating Technological Solutions To Mental Health Teaching And Assessment During The Pandemic. Poster session presented at the meeting of Australian and New Zealand College of Psychiatrists Congress 2022. Australian and New Zealand Journal of Psychiatry. |
| 2022 | Falk, A. J., Galletly, C., Just, D., Toben, C., Baune, B. T., Clark, S. R., . . . Schubert, K. O. (2022). BEYOND NEURORECEPTOR AUTOIMMUNITY: PERIPHERAL AUTOANTIBODY PROFILES ARE ASSOCIATED WITH CLINICAL FEATURES IN PSYCHOTIC DISORDERS. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. Sydney, NSW: SAGE PUBLICATIONS LTD. |
| 2019 | Lee, C., Sinclair, D., O'Donnell, M., Galletly, C., Liu, D., Weickert, C. S., & Weickert, T. (2019). Transcriptional changes in the stress pathway are related to symptoms in schizophrenia and to mood in schizoaffective disorder. Poster session presented at the meeting of Biological Psychiatry. Chicago, IL: Elsevier B.V.. DOI |
| 2019 | Weickert, T., Jacomb, I., Lenroot, R., Lappin, J., Weinberg, D., Brooks, W., . . . Weickert, C. S. (2019). Reduction in Peripheral C-Reactive Protein Levels With Canakinumab Administration is Related to Reduced Positive Symptom Severity in Patients With Schizophrenia and Inflammation. Poster session presented at the meeting of BIOLOGICAL PSYCHIATRY. Chicago, IL: ELSEVIER SCIENCE INC. DOI |
| 2018 | Galletly, C., Myles, H., Vincent, A., Myles, N., Adams, R., Chandratilleke, M., . . . Wittert, G. (2018). OBSTRUCTIVE SLEEP APNOEA IS COMMON IN SCHIZOPHRENIA AND RESPONDS WELL TO TREATMENT - A NOVEL AND PRACTICAL MEANS TO IMPROVE COGNITION AND METABOLIC HEALTH?. Poster session presented at the meeting of SCHIZOPHRENIA BULLETIN. Florence, ITALY: OXFORD UNIV PRESS. DOI |
| 2018 | Galletley, C., Ash, D., Sweeney, S., & Crichton, J. (2018). Conversing with people with thought disorder. Poster session presented at the meeting of Schizophrenia bulletin. UK: Oxford University Press. DOI |
| 2017 | Galletly, C., Gill, S., Clarke, P., Paterson, T., & Hahn, L. (2017). Attracting good rTMS habits: a workshop in the practical and clinical application of RTMS in psychiatry. Poster session presented at the meeting of RANZCP Abstracts. Adelaide, S.A.: Sage. DOI |
| 2017 | Galletly, C., Gill, S., Clarke, P., Paterson, T., & Hahn, L. (2017). Attracting good rTMS habits: a workshop in the practical and clinical application of RTMS in psychiatry. Poster session presented at the meeting of RANZCP Abstracts. Adelaide, S.A.: Sage. DOI |
| 2017 | Weickert, T., Jacomb, I., Stanton, C., Vasudevan, R., Powell, H., Liu, D., . . . Weickert, C. S. (2017). C-Reactive Protein as a Marker of Inflammation in Acute Psychosis and Schizophrenia. Poster session presented at the meeting of Abstracts, as published in Biological Psychiatry. San Diego, CA: ELSEVIER SCIENCE INC. DOI WoS1 |
| 2017 | Weickert, T., Kindler, J., Zavitsanou, K., Lim, C., Guillemin, G., Galletly, C., . . . Weickert, C. S. (2017). Dysregulation of Kynurenine Metabolism is Related to Proinflammatory Cytokines, Prefrontal Cortex Volume, and Attention in Schizophrenia. Poster session presented at the meeting of SCHIZOPHRENIA BULLETIN. San Diego, CA: OXFORD UNIV PRESS. DOI WoS1 |
| 2017 | Burgess, M., Boerrigter, D., Weickert, T., Lenroot, R., O'Donnell, M., Galletly, C., . . . Weickert, C. S. (2017). HOW RELIABLE ARE PERIPHERAL BIOMARKERS OF INFLAMMATION IN SCHIZOPHRENIA?. Poster session presented at the meeting of SCHIZOPHRENIA BULLETIN. San Diego, CA: OXFORD UNIV PRESS. |
| 2014 | Foley, D. L., Mackinnon, A., Morgan, V., Watts, G., Shaw, J., Magliano, D., . . . Galletly, C. (2014). Best buys for early intervention to improve cardiometabolic health in adults with psychosis: an Australian perspective. Poster session presented at the meeting of EARLY INTERVENTION IN PSYCHIATRY. WILEY-BLACKWELL. |
| 2013 | Looi, J. C. L., Kisely, S. R., Galletly, C., Macfarlane, M. D., Power, B. D., & Merry, S. N. (2013). RESEARCH IN THE RANZCP TRAINING PROGRAM. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. SAGE PUBLICATIONS LTD. |
| 2013 | Galletly, C., Fitzgerald, P., Gill, S., Rigby, A., Loo, C., & Martin, D. (2013). REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (rTMS) AND DIRECT CURRENT STIMULATION (DCS) TREATMENTS FOR PSYCHIATRIC DISORDERS - AN UPDATE FOR CLINICIANS. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. SAGE PUBLICATIONS LTD. |
| 2013 | Malhi, G., Galletly, C., Hay, P., & Walters, H. (2013). REVIEW OF THE RANZCP CLINICAL PRACTICE GUIDELINES 2013. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. SAGE PUBLICATIONS LTD. |
| 2012 | Morgan, V. A., Waterreus, A., Jablensky, A., Mackinnon, A., McGrath, J. J., Carr, V., . . . Saw, S. (2012). NOVEL DATA FROM A LARGE POPULATION PREVALENCE SURVEY: A UNIQUE OPPORTUNITY TO INFORM PSYCHOSIS RESEARCH DIRECTIONS AND MENTAL HEALTH REFORM. Poster session presented at the meeting of SCHIZOPHRENIA RESEARCH. ELSEVIER SCIENCE BV. DOI WoS1 |
| 2012 | Stain, H. J., Galletly, C., Clark, S., Wilson, J., Killen, E., Anthes, L., . . . Harvey, C. (2012). THE SOCIAL CONSEQUENCES FOR ADULTS EXPERIENCING PSYCHOSIS: FINDINGS FROM THE SECOND AUSTRALIAN NATIONAL SURVEY OF PSYCHOSIS. Poster session presented at the meeting of SCHIZOPHRENIA RESEARCH. ELSEVIER SCIENCE BV. DOI |
| 2011 | Galletly, C., Holmes, J., Murray, R., & Sachdev, P. (2011). THE BEST IN PSYCHIATRIC RESEARCH. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. INFORMA HEALTHCARE. |
| 2011 | Brennan, A., Harris, A., Williams, L., Galletly, C., Silverstein, S., Starling, J., & Nagy, M. (2011). SCHIZOPHRENIA AS A DISORDER OF "NEURAL INTEGRATION": LINKING BRAIN SYNCHRONY, COGNITION, EMOTION AND CLINICAL PROFILE. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. INFORMA HEALTHCARE. |
| 2011 | Galletly, C., Gill, S., Clarke, P., Kelly, D., Mckenny, B., Paterson, T., & Burton, C. (2011). NEUROSTIMULATION SYMPOSIUM. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. INFORMA HEALTHCARE. |
| 2011 | Burton, C., Neaves, A., Denson, L., & Galletly, C. (2011). FUNCTIONAL HEALTH LITERACY IN PEOPLE WITH MENTAL ILLNESS. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. INFORMA HEALTHCARE. |
| 2010 | Ash, D., Galletly, C., Singh, T., Burton, C., & Air, T. (2010). Metabolic risk factors and weight gain in people admitted to a psychiatric intensive care unit. Poster session presented at the meeting of Proceedings of 2nd Biennial Schizophrenia International Research Conference. Netherlands: Elsevier. DOI |
| Year | Citation |
|---|---|
| 2026 | Rossell, S. L., Meyer, D., Weickert, C., Tooney, P., Phillipou, A., Galletly, C., . . . Castle, D. (2026). Prevalence and Predictive Clinical Features of Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis in a Nationally Representative Sample of People with Psychosis. DOI |
NHMRC Grants
| 2021- 2025 | A National Research Translation Centre to implement Mental Health Care at Scale | NHMRC Special Initiative in Mental Health Grant 2021 CI on ALIVE | Led by A/Prof Victoria Palmer. | $10,000,000 |
| 2020 | Australasian Partnership for Improving Outcomes in Severe Depression. | NHMRC Partnership Projects, Australia: 1195643 | Loo, C., Martin, D., Mitchell, P.B., Hadzi-Pavlovic, D., Chatterton, M.L., Galletly, C., Hopwood, M., Sara, G. | $909,752.00 |
| 2016-2019 | Project Grant; Title: “N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial” | National Health and Medical Research Council (NHRMC), Australia: 1098442 | Castle, D., Rossell, S., Galletly, C., Harris, A., Francies, P., Siskind, D | $981,788.85 |
| 2016-2020 | Project Grant; Title: “An empirical framework for assessing mortality and morbidity in people with psychotic disorders: 7-year prospective and 10-year retrospective follow-up of 2075 participants in the Survey of High Impact Psychosis (SHIP) using linked registers” | National Health and Medical Research Council (NHRMC), Australia: 1102628 | Morgan, V., McGrath, J., Galletly, C., Harvey, C., Castle, D., Cohen, M., Jablensky, A., Carr, V., Neil, A., Wattereus, A | $626,179 |
| 2011-2012 | Grant, Title: “Australian Schizophrenia Research Bank”, (extension) | National Health and Medical Research Council (NHRMC), Australia: 386500 | Carr, V., Schall, U., Scott, R., Jablensky, A., Mowry, B., Michie, P., Catts, S., Henskens, F., Pantelis, C., Loughland, C., Tooney, P., Rasser, P., Lewin, T., Stain, H,MM Badcock, J., Morgan, V., de Zubicaray, G., Budd, B., Seal, M., Soulsby, B., Velakoulis, D., Kader, L., Kalaydjieva, L., Weickert, T., Galletly, C; Enabling | $440,650 |
| 2006-2011 | Enabling Grant, Title: “Australian Schizophrenia Research Bank” | National Health and Medical Research Council (NHRMC), Australia: 386500 | Carr, V., Schall, U., Scott, R., Jablensky, A., Mowry, B., Michie, P., Catts, S., Henskens, F., Pantelis, C., Loughland, C., Tooney, P., Rasser, P., Lewin, T., Stain, H,mm Badcock, J., Morgan, V., de Zubicaray, G., Budd, B., Seal, M., Soulsby, B., Velakoulis, D., Kader, L., Kalaydjieva, L., Weickert, T., Galletly, C | $1,750,000 |
| 2007-2009 | Research Grant; Title: “Childhood cognitive antecedents of adult psychopathology: follow up of the Port Pirie lead cohort into adulthood” | National Health and Medical Research Council (NHMRC), Australia: ID 453563 | McFarlane A, Galletly C, Sim M, Sawyer M, Baghurst P | $587,263 |
MRFF
| 2021-2026 | Mental Health Australia General Clinical Trial Network (MAGNET). One of 50 Chief Investigators, working across diverse areas to build MAGNET: the first Australia-wide clinical trials network in adult mental health. | Medical Research Future Fund (MRFF) CI on 2020 Million Minds Mission Mental Health Research Grant, Australia: 2006296 | led by M Berk. | $11,998,907 |
The Hospital Research Foundation
| 2020 | Establishing and Evaluating a Mental Health Single Entry Point (SEP) to Improve Depression Care for Young People. | The Hospital Research Foundation Translational Grant, Adelaide | Schubert, O., Galletly, C., Clark, S., Wright, S. | $70,000 |
Commonwealth Department of Health and Ageing
| 2009-2011 | Research Grant; Title: “National Survey of High Impact Psychosis (SHIP)” | Commonwealth Dept of Health and Ageing, Australia | Jablensky A, Bush R , Carr V, Castle D, Galletly C, Harvey C, Hocking B, Mackinnon A , McGorry P, Morgan V, McGrath J, Stain H, Waterreus A, Neil A, Saw S | $6,155,514 |
ARC Linkage Grant
| 2011-2013 | Linkage Grant; Title: “Stopping the run-around: comorbidity action in the north (CAN)” | Australian Research Council, Australia: LP110100087 | de Crespigny CF, Galletly C, Athanasos P, Procter NG, Moss JR, Rowlands CE, Liu DT, Tyllis P, Chong AJ, Lee D | $275,820 |
The Stanley Medical Research Institute (USA)
| 2013 | Canakinumab adjunctive treatment trial to reduce symptoms and improve cognition in patients with schizophrenia displaying elevated peripheral IL-1beta | The Stanley Medical Research Institute . | Weickert, T.W., Weickert, C.S., Catts, S.V., Lenroot, R., Galletly, C., Wakefield, C., Lloyd A | USD $361,132 |
Course Coordination
2011-2020 - MBBS Year 6 Course Convenor
- Regular tutorial teaching for Year 6 Program – ‘Early mortality in people with schizophrenia – why?’
2003–2013 - MBBS Year 6 Psychiatry clinical placements (The Adelaide Clinic)
2003–2007 - MBBS Years 4 and 6 Psychiatry clinical placements (LMHS)
2004–2007 - Medical and Scientific attachment, MBBS years 4 and 5
MBBS Committees
2011-2020 - Curriculum Committee
2011-2021 - Assessment Committee
2011-2019 - Scientific Basis of Medicine Committee
Examiner / Assessor
2011-2019 - Board of Examiners, Year 4/5 MBBS
2003-2019 - Board of Examiners, Year 6 MBBS
1996 (ongoing) - Assessor for clinical competence, written and OSCI examinations, various year levels MBBS
Seminar / Tutorial / Lecture Teaching
1996 (ongoing) - Participation in teaching at various year levels MBBS
2005 (ongoing) - Tutorial teaching, year 6, MBBS psychiatry
2010-2019 - Coordinate and teach Tranisition to Internship teaching in psychiatry, Year 6 MBBS
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2014 - 2020 | Principal Supervisor | Schizophrenia and Obstructive Sleep Apnoea | Doctor of Philosophy | Doctorate | Part Time | Dr Hannah Dawn Myles |
| 2013 - 2017 | Principal Supervisor | Health Risk Factors Associated with Morbidity and Mortality in a National Sample of People with Psychosis | Doctor of Philosophy | Doctorate | Full Time | Miss Lisa Anne Hahn |
| 2011 - 2016 | Principal Supervisor | Brave in their New World: Service Provision for Refugee Youth with Comorbidity in Northern Metropolitan Adelaide | Doctor of Philosophy | Doctorate | Full Time | Ms Miriam Tamsin Posselt |
| 2011 - 2015 | Co-Supervisor | Addressing Aboriginal Community People's Mental Health and Alcohol and Drug Comorbidity Service needs in the Salisbury and Playford Local Government Areas of South Australia | Doctor of Philosophy | Doctorate | Full Time | Mrs Hepsibah Sharmil Francis Jebaraj |
| 2010 - 2015 | Principal Supervisor | Resilience, Psychosis and Childhood Trauma | Doctor of Philosophy | Doctorate | Full Time | Mr Shaun Michael David Sweeney |
| 2007 - 2012 | Co-Supervisor | The Role of Cognitive Biases in the Development, Maintenance and Treatment of Delusional Belief across the Psychosis Continuum | Doctor of Philosophy | Doctorate | Full Time | Dr Ryan Balzan |
| 2007 - 2013 | Co-Supervisor | A Qualitative Study of Medication Adherence Amongst People with Schizophrenia | Master of Psychology (Clinical)/Doctor of Philosophy | Doctorate | Full Time | Ms Lucinda Clifford |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2015 - ongoing | Member | SA Psychiatry Training Committee | - | - |
| 2015 - ongoing | Co-Chair | Scientific Committee, RANZCP Annual Congress, Adelaide 2017 | - | - |
| 2013 - 2016 | Chair | Working group to revise RANZCP Clinical Practise Guidelines on Schizophrenia and Related Disorders | RANZCP | Australia |
| 2011 - ongoing | Chair | MBBS Year 6 Course Committee | The University of Adelaide | - |
| 2011 - ongoing | Member | MBBS Curriculum Committee | The University of Adelaide | - |
| 2011 - ongoing | Member | MBBS Assessment Committee | The University of Adelaide | - |
| 2006 - ongoing | Member | Medical Advisory Committee | Ramsay Health Care (SA) Mental Health | - |
| 2006 - ongoing | Member | Research Committee, School of Medicine | The University of Adelaide | - |
| Date | Role | Membership | Country |
|---|---|---|---|
| 2010 - ongoing | - | Australian Medical Association | - |
| 2010 - ongoing | - | Society for Mental Health Research | - |
| 2010 - 2019 | Member | European Association of Threat Assessment Professionals | Australia |
| 2010 - 2018 | Member | Collegium Internationale Neuro-psychopharmacologium | Australia |
| 2010 - 2018 | Member | European College of Neuropsychopharmacology | Australia |
| 2010 - 2017 | Member | International Society for Affective Disorders | Australia |
| 2010 - ongoing | - | Royal Australian & New Zealand College of Psychiatrists | - |
| 2010 - ongoing | - | RANZCP Section for Neurosciences | - |
| 2010 - ongoing | - | Schizophrenia International Research Society | - |
| Date | Role | Editorial Board Name | Institution | Country |
|---|---|---|---|---|
| 2014 - ongoing | Board Member | Andhra Pradesh Journal of Psychological Medicine | - | - |
| 2013 - ongoing | Editor | Schizophrenia, Frontiers in Psychiatry | Schizophrenia, Frontiers in Psychiatry | Australia |
| 2011 - 2021 | Associate Editor | Australian and New Zealand Journal of Psychiatry | Australian and New Zealand Journal of Psychiatry | Australia |
| 2011 - 2020 | Member | Editorial Executive Committee, Australian Prescriber (National Prescribing Service) | Australian Prescriber | Australia |
| 2011 - ongoing | Consulting Editor | World Journal of Pharmacology | - | - |